.png)
COVID-19 Evidence Reviews
as of 8/13/20
Unpublished Reviews
= living review
= draft/preprint | 
= meets mimimum quality standards | A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
  |
report
|
select |
|---|---|---|
|
8/12/20
|
Thakkar S, Arora S, Kumar A, et al. | medRxiv
Aim: To provide a foundation for understanding the CV manifestations and outcomes of COVID-19.
|
|
|
8/12/20
|
Khorramizadeh M, Arab-bafrani Z, Mosavi E | PROSPERO
|
|
|
8/12/20
|
Sahoo KC, Pati S, Dash GC, et al | PROSPERO
|
|
|
8/12/20
|
Chacko J, Brar G, Premkumar R | medRxiv
Aim: To evaluate the efficacy and safety of hydroxychloroquine among patients with COVID 19 infection.
|
|
|
8/12/20
|
de Oliveira JD, Lago MF, Sarandy MM, et al | PROSPERO
|
|
|
8/12/20
|
Lim JL, Subramaniam A | PROSPERO
|
|
|
8/12/20
|
Tunjungputri RN, Tetrasiwi EN, Rizqa T, et al | PROSPERO
|
|
|
8/12/20
|
Li X, Liu C, Mao Z, et al | PROSPERO
|
|
|
8/12/20
|
Ramos HMP, Franco ACD, Ronca D, et al | PROSPERO
|
|
|
8/12/20
|
Tian Y, Chen H, Xie Y | PROSPERO
|
|
|
8/12/20
|
Sarkar S, Khanna P, Singh A | PROSPERO
|
|
|
8/12/20
|
Pickford R, Woeckel M, Schneider A, et al | PROSPERO
|
|
|
8/12/20
|
Wells V, Thomas-Meyer M, Gentry S, et al | PROSPERO
|
|
|
8/12/20
|
Sarma P, Bhattacharyya A, Kaur H, et al | PROSPERO
|
|
|
8/12/20
|
Tractenberg SG, Viola TW, Grassi-Oliveira R | PROSPERO
|
|
|
8/12/20
|
Neil-Sztramko S, Dobbins M, Anderson L, et al | PROSPERO
|
|
|
8/11/20
|
Batra K, Batra R, Sharma M, et al | PROSPERO
|
|
|
8/11/20
|
Ismail S, Babonji A, Al Harbi S, et al | PROSPERO
|
|
|
8/11/20
|
Honarmand K, Rochwerg B, Siemieniuk R, et al | PROSPERO
|
|
|
8/11/20
|
Ayub A, Agarwal N, Mishra S | PROSPERO
|
|
|
8/11/20
|
Bhamani S, Lassi Z, Rashid M, et al | PROSPERO
|
|
|
8/11/20
|
Walz L, Cohen AJ, Rebaza AP, et al. | medRxiv
Aim: To evaluate role of Janus-kinase inhibitors and Type I interferons in COVID-19 patients.
|
|
|
8/11/20
|
Yin TX, Luo Z | PROSPERO
|
|
|
8/11/20
|
Shi J, Li Y, Zhao L, et al. | Research Square
|
|
|
8/11/20
|
Heneghan C, Spencer E, Brassey J, et al. | medRxiv
Aim: To identify and evaluate relevant articles (peer-reviewed or awaiting peer review) that examine the mode of viral transmission and ecological variables influencing the mode of transmission.
|
|
|
8/11/20
|
Campbell J, Bastos M, Perlman-Arrow S, et al | PROSPERO
|
|
|
8/11/20
|
Michel S, von Ehrenstein O | PROSPERO
|
|
|
8/11/20
|
Jarrom D, Elston L, Washington J, et al. | medRxiv
Aim: To identify evidence on: (1) the clinical effectiveness of tests that detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) to inform COVID?19 diagnosis? and (2) the clinical effectiveness of tests that detect the presence of antibodies to the SARS?CoV?2 virus to inform COVID?19 diagnosis.
|
|
|
8/11/20
|
Yang L, Chen X | PROSPERO
|
|
|
8/11/20
|
Zaki N, Mohamed EA | medRxiv
Aim: To undertake a review and critical appraisal of all published/preprint reports that offer an estimation of incubation periods for novel coronavirus (COVID-19).
|
|
|
8/11/20
|
Yang J, Chen Y, Tian C, et al | PROSPERO
|
|
|
8/10/20
|
Singh P, Pratap S, Bhoil R | PROSPERO
|
|
|
8/10/20
|
Yang L, Cao S, Huang J | PROSPERO
|
|
|
8/10/20
|
Sandoval C, Carrasco C, Carrasco D, et al | PROSPERO
|
|
|
8/10/20
|
Abate S, Basu B, Mantefardo B | PROSPERO
|
|
|
8/10/20
|
Mozaffari H, Darand M, Raeisi T, et al | PROSPERO
|
|
|
8/10/20
|
Ma H, Yang L, Guo H | PROSPERO
|
|
|
8/10/20
|
Necho M, Tsehay M, Belete A | PROSPERO
|
|
|
8/10/20
|
Henrina J, Pranata R | PROSPERO
|
|
|
8/10/20
|
Christol RO, Tinica G, Furnica C, et al | PROSPERO
|
|
|
8/10/20
|
Sabe M, Dorsaz O, Kaiser S, et al | PROSPERO
|
|
|
8/7/20
|
Wang X, Xie P, Sun G, et al | Medicine
|
|
|
8/7/20
|
Fantin K, Nelson T, Mehdi A | PROSPERO
|
|
|
8/7/20
|
Li Y, Xu Y, Shi P, et al. | Medicine
|
|
|
8/7/20
|
Qi M, Jones C, Li P, et al | PROSPERO
|
|
|
8/7/20
|
Li R, Li Y, Li B, et al. | Medicine
|
|
|
8/7/20
|
Patell R, Chiasakul T, Bauer E, et al | PROSPERO
|
|
|
8/7/20
|
Sheng Z, Zhang L, Liu X, et al. | Medicine
|
|
|
8/7/20
|
Henrina J, Pranata R, Lawrensia D, et al | PROSPERO
|
|
|
8/7/20
|
Patel K, Huntley C, Mobeen F, et al | PROSPERO
|
|
|
8/7/20
|
Shi Y, Wen D, Wang H, et al. | Medicine
|
|
|
8/7/20
|
Wang Y, Ao G, Qi X, et al | PROSPERO
|
|
|
8/7/20
|
Medeiros G, Nunes A, Azevedo K, et al. | Medicine
|
|
|
8/7/20
|
Abdelaal A, Alkhatip AMM, Kamel MG, et al | PROSPERO
|
|
|
8/7/20
|
Li Y, Xu H, Lang H, et al. | Medicine
|
|
|
8/7/20
|
Khanna P, Sarkar S, Singh A | PROSPERO
|
|
|
8/7/20
|
Gu R, Xu S, Li Z, et al. | Medicine
|
|
|
8/7/20
|
Li L, Chen X, Yang W, et al. | Medicine
|
|
|
8/7/20
|
Vardoulkis S | PROSPERO
|
|
|
8/6/20
|
Mendes NF, Jara CP, Mansour E, et al. | Research Square
Aim: To review the evidence on the description of asthma as a premorbid condition and its putative association with severe progression of the disease.
|
|
|
8/6/20
|
Henschke N, Villanueva G, Cogo E | PROSPERO
|
|
|
8/6/20
|
Wang J, Tang H | PROSPERO
|
|
|
8/6/20
|
Cui L, Cheng W, Chen M | PROSPERO
|
|
|
8/6/20
|
Veluri N | PROSPERO
|
|
|
8/6/20
|
Zhang Y, Ren T, Li H, et al | PROSPERO
|
|
|
8/6/20
|
Keegan D, Heffernan E, Masterson S | PROSPERO
|
|
|
8/6/20
|
AlvesVP, Casemiro FG, de Araujo BG, et al | PROSPERO
|
|
|
8/6/20
|
Turner S, Botero N, Nino A, et al | PROSPERO
|
|
|
8/6/20
|
Necho M, Belete A, Getachew Y | PROSPERO
|
|
|
8/6/20
|
Peeters E, Kaur Dhillon Ajit Sing S, Vandesompele J, et al. | medRxiv
Aim: To assess the diagnostic sensitivity of SARS-CoV-2 testing on saliva compared to NP swabs.
|
|
|
8/6/20
|
Sheng X, Zhou R, Tan Y | PROSPERO
|
|
|
8/6/20
|
Roshandel E, Kazemi MH, Dehaghi BK, et al. | Research Square
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients.
|
|
|
8/6/20
|
Xu N, Li T, Huang M | PROSPERO
|
|
|
8/6/20
|
Fernandes N, Antunes M | PROSPERO
|
|
|
8/6/20
|
Vindrola C, Sidhu M, Singh K, et al | PROSPERO
|
|
|
8/5/20
|
Ali R, Al-Jageka C, Bhasin A, et al | PROSPERO
|
|
|
8/5/20
|
Lazarus G, Audrey J, Wangsaputra V, et al | PROSPERO
|
|
|
8/5/20
|
Li Y, Li J, Zhong D, et al. | Syst Rev
|
|
|
8/5/20
|
Hoekstra EM, Neumann KMI, Boot PC, et al. | Research Square
Aim: To evaluate the effect of corticosteroids on mortality, viral clearance and secondary outcomes in COVID-19 patients.
|
|
|
8/5/20
|
da Cunha Sa Caputo D, Coelho de Oliveira AC, Sonza A, et al | PROSPERO
|
|
|
8/5/20
|
Zhong Y, Wang K, Zhu Y, et al | PROSPERO
|
|
|
8/5/20
|
Liu S, Cao Y, Zhi Y | PROSPERO
|
|
|
8/5/20
|
de Amaral LC, Calado RD, Teixeira AM, et al. | Research Square
Aim: To map how Lean tools are being used in healthcare and what are their results, including those related to humanization.
|
|
|
8/5/20
|
Udeh R, Majeed T, Manuel J | PROSPERO
|
|
|
8/5/20
|
Haile T, Mariye T, Gebremeskel G, et al | PROSPERO
|
|
|
8/5/20
|
Khanna P, Sarkar S, Singh A | PROSPERO
|
|
|
8/5/20
|
Su K, Liu S, Li J, et al | PROSPERO
|
|
|
8/5/20
|
The incidence, demographics, management and outcomes of pulmonary embolism in patients with COVID-19
Mansuri Z, Sharma K | PROSPERO
|
|
|
8/5/20
|
Zereabruk K, Aberhe W, Mebrahtom G, et al | PROSPERO
|
|
|
8/5/20
|
Aberhe W, Hailay A, Zereabruk K, et al | PROSPERO
|
|
|
8/5/20
|
Elsayed HH, Hassaballa AS, Ahmed TA, et al. | Research Square
Aim: To review the evidence on IMV for COVID-associated ARDS to study its outcome among different countries.
|
|
|
8/5/20
|
Yisak H, Ewunetei A, Teshome F, et al | PROSPERO
|
|
|
8/4/20
|
Qian L | PROSPERO
|
|
|
8/4/20
|
Patwary MM, Shuvo FK, Dendup T, et al | PROSPERO
|
|
|
8/4/20
|
Chi C, Sun J | PROSPERO
|
|
|
8/4/20
|
Zhang X, Hong T, Lin L | PROSPERO
|
|
|
8/4/20
|
Cosco TD, Davis D, Conroy S | PROSPERO
|
|
|
8/4/20
|
Lazarus G, Rinaldi I | PROSPERO
|
|
|
8/4/20
|
Routhier F, Lebrasseur A, Fortin-Bedard N, et al | PROSPERO
|
|
|
8/4/20
|
Capucho H | PROSPERO
|
|
|
8/4/20
|
Deo KB, Shrestha R, Kumar-M P, et al | PROSPERO
|
|
|
8/4/20
|
Thompson CE, Rotta LN, Santos AS, et al | PROSPERO
|
|
|
8/4/20
|
Stuijfzand S, Deforges C, Sandoz V, et al. | Research Square
Aim: To synthesize the evidence on the psychological impact of pandemics/epidemics on the mental health of HCPs, what factors predict this impact, and the evidence of prevention/intervention strategies to reduce this impact.
|
|
|
8/4/20
|
Dominic C, Bhalla G, Khare Y, et al | PROSPERO
|
|
|
8/4/20
|
Hailay A, Aberhe W, Zereabruk K, et al | PROSPERO
|
|
|
8/4/20
|
Jia N, Sun X, Wang Y, et al | PROSPERO
|
|
|
8/4/20
|
Zhang H, Zhang H, Zhang X, et al | PROSPERO
|
|
|
8/4/20
|
Kotepui M, Masangkay FR, Kotepui KU, et al | PROSPERO
|
|
|
8/4/20
|
Aberhe W, Hailay A, Zereabruk K, et al | PROSPERO
|
|
|
8/4/20
|
Hashemimadani N, Emami Z, Janani L, et al. | Research Square
Aim: To assess the relationship between different chest CT features and severity of clinical presentation in COVID-19.
|
|
|
8/4/20
|
Jefferson T, Spencer EA, Brassey J, et al. | medRxiv
Aim: To review the evidence comparing SARS-CoV-2 culture with reverse transcriptase polymerase chain reaction (rt-PCR).
|
|
|
8/3/20
|
Alves da Silva J, Capucho H | PROSPERO
|
|
|
8/3/20
|
Moya-Salazar J, Contreras-Pulache H, Moya-Espinoza J | PROSPERO
|
|
|
8/3/20
|
COVID-19 (SARS-CoV-2) infection and its relationship with thrombotic conditions: a systematic review
Miranda ML, Gabbai-Armelin P, Sales LS, et al | PROSPERO
|
|
|
8/3/20
|
Perez Y, Li J, Tavernier E, et al | PROSPERO
|
|
|
8/3/20
|
Xie Y, Wang Z, Liao H, et al. | Research Square
Aim: To summarize the epidemiologic traits, clinical spectrum, CT results and laboratory findings of the COVID-19 pandemic.
|
|
|
8/3/20
|
Zereabruk K, Aberhe W, Hailay A, et al | PROSPERO
|
|
|
8/3/20
|
Furtado S, dos Santos Lucas AC, Basilio Carneiro AL, et al | PROSPERO
|
|
|
8/3/20
|
Kyriazopoulou E, Giamarellos-Bourboulis E, Reinhart K, et al | PROSPERO
|
|
|
8/3/20
|
Xiong X, Nie R | PROSPERO
|
|
|
8/3/20
|
Sirois F, Owens J | PROSPERO
|
|
|
8/2/20
|
Mahdi SS, Ahmed Z, Allana R, et al. | Research Square
Aim: To review all the relevant literate published so far on dental aspects of Covid-19 in order to serve as point of synthesis for future recommendations and guidelines for dental practices.
|
|
|
8/2/20
|
Arab-zozani M, Hassanipour S, Ghoddoosi-Nejad D | BMJ Open
|
|
|
8/1/20
|
Salcher-Konrad M, Jhass A, Naci H, et al. | medRxiv
Aim: To synthesise early international evidence on mortality rates and incidence of COVID-19 among people who use and provide LTC.
|
|
|
8/1/20
|
Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate
Madewell ZJ, Yang Y, Longini IM, et al. | medRxiv
Aim: To review the evidence on the spread of SARS-CoV-2 by direct, indirect, or close contact with infected people in indoor environments.
|
|
|
8/1/20
|
Fernandez Villalobos NV, Ott J, Klett-Tammen C | medRxiv
Aim: To review the evidence on the associations between comorbidities and behavioural factors with hospitalisation, Intensive Care Unit (ICU) admission, and death due to COVID-19.
|
|
|
7/31/20
|
Park M, Pawliuk C, Nguyen T, et al. | medRxiv
Aim: To identify the reported communicable period of SARS-CoV-2.
|
|
|
7/31/20
|
Szczepura A, Krishnan N, Gumber A, et al | PROSPERO
|
|
|
7/31/20
|
Zhang Q, Jiang Y | PROSPERO
|
|
|
7/31/20
|
Jimenez D, Rali P, Muriel A, et al | PROSPERO
|
|
|
7/31/20
|
Lahiri D, Mondal R, Deb S, et al | PROSPERO
|
|
|
7/31/20
|
Marzaleh MA, Ghahramani S | PROSPERO
|
|
|
7/31/20
|
Zhao X, Han G, Gang X | PROSPERO
|
|
|
7/31/20
|
Almaqbali M | PROSPERO
|
|
|
7/31/20
|
Darmarkusuma A, Nugroho DB, Chandra LA, et al | PROSPERO
|
|
|
7/31/20
|
Browne M, Sing HH, Keith-Jopp CKJ, et al | PROSPERO
|
|
|
7/30/20
|
Chivese T, Musa OAH, Hindy G, et al. | medRxiv
Aim: To synthesize the findings presented in systematic reviews and meta-analyses as well as to update the evidence using a meta-analysis in evaluating the efficacy and safety of CQ and HCQ with or without Azithromycin for the treatment of COVID19 infection.
|
|
|
7/30/20
|
Poudel G, Parsons N, Clohesy R, et al | PROSPERO
|
|
|
7/30/20
|
Hu Y, Xiong J, Chen L, et al. | Research Square
Aim: To summarize the existing literature on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in newborns to clarify the clinical features and outcomes of neonates with COVID-19.
|
|
|
7/30/20
|
Li Y, Zhong D, Zhang Y, et al. | Research Square
|
|
|
7/30/20
|
Griswold D, Gempeler A, Kolias A, et al | PROSPERO
|
|
|
7/30/20
|
Zhao B, Liu K, Lei S, et al. | Research Square
Aim: To investigate the prevalence of elevated troponins in these patients and its prognostic value for predicting mortality.
|
|
|
7/30/20
|
Chivese T, Musa O | PROSPERO
|
|
|
7/29/20
|
Maidment I, Young E, Wong G, et al | PROSPERO
|
|
|
7/29/20
|
Anderson L, Griffith L, Balion C | PROSPERO
|
|
|
7/29/20
|
Santos M, Torres D, Cardoso PC, et al. | medRxiv
Aim: To investigate the efficiency of cloth masks in reducing transmission and contamination by droplets and aerosols for the general population and healthcare workers.
|
|
|
7/29/20
|
Jaber M, Hassan A, AlQahtani F, et al | PROSPERO
|
|
|
7/29/20
|
Liu Y, Lu Huan, Wang W, et al | PROSPERO
|
|
|
7/29/20
|
Mao Z, Ong ACM | PROSPERO
|
|
|
7/29/20
|
Oladimeji K, Dahman NBH, El Shahaway AES, et al | PROSPERO
|
|
|
7/29/20
|
Grenet G, Mekhaldi S, Mainbourg S, et al. | medRxiv
Aim: To estimate the effect of DPP4 inhibitors on the risk of respiratory infections.
|
|
|
7/29/20
|
Menear M, Rice D | Universite Laval
|
|
|
7/29/20
|
Saez M, Barceli MA, Tobias A, et al | PROSPERO
|
|
|
7/29/20
|
Raschetti R, Vivanti A, Vauloup C, et al. | Research Square
Aim: To clarify the main transmission route, clinical features and outcomes of neonatal SARS-CoV-2 infections
|
|
|
7/29/20
|
Miller J, Lee S | PROSPERO
|
|
|
7/29/20
|
Gupta A, Ng SM, Mouyis K, et al | PROSPERO
|
|
|
7/29/20
|
Kefale B, Temesgen G, Degu A, et al | PROSPERO
|
|
|
7/29/20
|
Tirfe M, Berhane H, Teklu T | PROSPERO
|
|
|
7/29/20
|
Cevik M, Tate M, Lloyd O, et al. | medRxiv
Aim: To characterise viral load dynamics, duration of viral RNA, and viable virus shedding of SARS-CoV-2 in various body fluids and to compare SARS-CoV-2 viral dynamics with SARS-CoV-1 and MERS-CoV.
|
|
|
7/29/20
|
Gupta A, Ng SM, Mouyis K, et al | PROSPERO
|
|
|
7/29/20
|
Siegel A | PROSPERO
|
|
|
7/29/20
|
Mayr V, Anna G, Gartlehner G, et al. | Research Square
Aim: To determine the frequency of CNS manifestations of COVID-19 (CNS symptoms, acute cerebrovascular disease, and infectious/inflammatory CNS diseases) and to summarize the current evidence for direct invasion of the CNS by SARS-CoV-2.
|
|
|
7/28/20
|
Pearce S, Cruz E, Brickley E, et al | PROSPERO
|
|
|
7/28/20
|
A systematic review of the effectiveness of Acceptance and Commitment Therapy (ACT) compared with other psychological therapies in managing grief experienced by bereaved spouses or partners of adults who had received palliative care worldwide | PROSPERO
|
|
|
7/28/20
|
Mamuye M, Yisake H, Teshome F, et al | PROSPERO
|
|
|
7/28/20
|
Buitrago-Garcia DC, Egli-Gany D, Counotte MJ, et al. | medRxiv
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission.
|
|
|
7/28/20
|
Hydoub YM, Nour S, Al Zubaidi AM | PROSPERO
|
|
|
7/28/20
|
Moursi A, Taha SHN, Ramadan A | medRxiv
Aim: To assess the cure rate, duration of hospital stay, radiological progression, clinical worsening, need for mechanical ventilation, the occurrence of side effects, and mortality.
|
|
|
7/28/20
|
Coon JT, Whear R, Abbott R, et al | PROSPERO
|
|
|
7/28/20
|
Pasin L, Landoni G | PROSPERO
|
|
|
7/28/20
|
Isaacs Z, Guinness L | PROSPERO
|
|
|
7/28/20
|
Knowledge, attitude and practice of students towards COVID-19: a systematic review and meta-analysis
Alam MA, Patwary MM, Hossain MR, et al | PROSPERO
|
|
|
7/28/20
|
Gao W, Huang G, Li J | PROSPERO
|
|
|
7/28/20
|
Jomaa MK, Srour S, Geng Y, et al | PROSPERO
|
|
|
7/28/20
|
Liu H, Yang D, Zou Y, et al | PROSPERO
|
|
|
7/28/20
|
Ma Q, Wu L, Yang Z, et al | PROSPERO
|
|
|
7/28/20
|
Qin Q, Chen B, Wang Y, et al | PROSPERO
|
|
|
7/28/20
|
Zhangmeng X, Yong C, Yaming Y, et al | PROSPERO
|
|
|
7/28/20
|
Alexandrina de Araujo T, Ferreira de Moura R, Oliveira de Almeida N | PROSPERO
|
|
|
7/28/20
|
Kiyumi MA, Kalhan A | PROSPERO
|
|
|
7/27/20
|
Tan RQ, Li WTV, Shum W, et al. | Research Square
Aim: To conduct a systematic review and meta-analysis of peer-reviewed articles, which described clinical data of smell disturbances and OD in COVID-19 patients.
|
|
|
7/27/20
|
Sales-Peres S, Azevedo-Silva L, Sales-Peres M | PROSPERO
|
|
|
7/27/20
|
Sardar S, Sharma R, Elshafei MN, et al | PROSPERO
|
|
|
7/27/20
|
Syangtan G, Bista S, Dawadi P, et al. | Research Square
Aim: To appraise the burden of asymptomatic individuals and estimate their occurrence among different age groups and gender by reviewing the existing published data on asymptomatic people with COVID-19.
|
|
|
7/27/20
|
Mohamed MA, Cheng C, Xiang W | PROSPERO
|
|
|
7/27/20
|
Prado PAB, Vasquez AAH, Comande D, et al | PROSPERO
|
|
|
7/27/20
|
Parry M, Bjornnes AK, Nickerson N, et al. | CIHR IRSC
Aim: To determine what is known about the mental health and wellbeing of family caregivers during communicable disease outbreaks.
|
|
|
7/27/20
|
Babata KL, Yeo KT, Chan CS, et al. | Cochrane Database of Systematic Reviews
|
|
|
7/27/20
|
Sales-Peres S, Azevedo-Silva L, Castilho AV, et al | PROSPERO
|
|
|
7/27/20
|
Chan CS, Kong JY, Babata KL, et al. | Cochrane Database of Systematic Reviews
|
|
|
7/27/20
|
Goncalves PM, Cuccarese VHE, Cabrera AAC | PROSPERO
|
|
|
7/27/20
|
Desse TA, Barhane AM | PROSPERO
|
|
|
7/27/20
|
Zhang Y | PROSPERO
|
|
|
7/27/20
|
Wildwing T, Holt N, et al. | medRxiv
Aim: To provide health professionals with better accessibility to available evidence, this paper summarises findings from a systematic overview of systematic reviews of the neurological symptoms seen in patients with COVID-19.
|
|
|
7/27/20
|
Zhang G | PROSPERO
|
|
|
7/27/20
|
Koizumi T, Sugimoto K, Ohnota S, et al | PROSPERO
|
|
|
7/27/20
|
Huang X, Huang P, Zheng J, et al | PROSPERO
|
|
|
7/27/20
|
Bayley H, Ayabina D, Hollingsworth TD | PROSPERO
|
|
|
7/25/20
|
Juneau CE, Briand AS, Pueyo T, et al | medRxiv
Aim: To examine contact tracing effectiveness in the context of COVID-19.
|
|
|
7/25/20
|
Liu D, You Y, Chen Y, et al. | Medicine
|
|
|
7/25/20
|
Karimzadeh S, Bhopal R, Nguyen HT | Preprints
Aim: To review the literature on SARS-CoV-2 viral dynamics and their correlation with outcome.
|
|
|
7/24/20
|
Wu G, Jiang P, Yuan H, et al. | Research Square
Aim: To evaluate the efficacy of N95 respirators and medical masks for protection against respiratory infectious diseases, including COVID-19.
|
|
|
7/24/20
|
Ghotme KA, Barragan LA, Guerrero JI, et al | PROSPERO
|
|
|
7/24/20
|
Demis A, Getie A, Gedefaw, et al | PROSPERO
|
|
|
7/24/20
|
Banakar M, Lankarani KB, Jafarpour D, et al. | Research Square
Aim: To examine the risk of the transmission of the COVID–19 during dental treatments and provides pathways and protective protocols to minimize them, bearing in mind the long-term necessity of actions and realistic, practical measures.
|
|
|
7/24/20
|
Weeks R, Limaye R, Wahl B, et al | PROSPERO
|
|
|
7/24/20
|
Van de Sande DGMM, Van Genderen ME, Huiskens J, et al | PROSPERO
|
|
|
7/24/20
|
Tripathy S, Varghese P, Panda BB, et al | PROSPERO
|
|
|
7/24/20
|
Gomes Z, Aithal S, Antonipillai V, et al | PROSPERO
|
|
|
7/24/20
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
7/24/20
|
Cheruiyot I, Sehmi P, Ngure B, et al | PROSPERO
|
|
|
7/24/20
|
Stephenson A, Howes S, McDonough S, et al | PROSPERO
|
|
|
7/24/20
|
Fathalipour M, Noormandi A, Hassanipour S | PROSPERO
|
|
|
7/24/20
|
The imapct of inequality on metnal health outcomes during the COVID-19 pandemic: a systematic review
Schneider J, Gibson B, Talamonti D, et al | PROSPERO
|
|
|
7/24/20
|
Lee Y, McIntyre R | PROSPERO
|
|
|
7/24/20
|
Gyanpuri V, Dhiman N, Pathak A, et al. | Research Square
|
|
|
7/24/20
|
Niburski K, Yan LR, Mamane S | PROSPERO
|
|
|
7/23/20
|
Yigezu A, Mengistu M, Mikuzie A | Research Square
Aim: To systematically review economic evaluation of interventions to respond to coronavirus pandemics in the global perspective.
|
|
|
7/23/20
|
Chambergo-Michilot D, Branez-Condorena A, Martinez-Rivera RN, et al | PROSPERO
|
|
|
7/23/20
|
Shukla P, Tiwari A, Ghosh A, et al | PROSPERO
|
|
|
7/23/20
|
Wu G, Jiang P, Yuan H, et al. | Research Square
Aim: To evaluate the efficacy of N95 respirators and medical masks for protection against respiratory infectious diseases, including COVID-19.
|
|
|
7/23/20
|
Parashar S, Karthik AR, Gupta R | PROSPERO
|
|
|
7/23/20
|
Yuan X, Dongmei W, Mingying L, et al | PROSPERO
|
|
|
7/23/20
|
Thrinuavukkarasu S, Tapp R, Tina Cao | PROSPERO
|
|
|
7/23/20
|
Shaheed CA, Beardsley J, Saxena M, et al | PROSPERO
|
|
|
7/23/20
|
Bzeizi K, Abdulia M, Mohammed N, et al. | Research Square
Aim: To assess the available evidence on the clinical effects of SARS-CoV-2 on liver function laboratory tests and coagulation profile in affected individuals.
|
|
|
7/23/20
|
Sasongko TH, Kademane K, Cummins A, et al | PROSPERO
|
|
|
7/23/20
|
Bae S, Kim SR, Park SM, et al | PROSPERO
|
|
|
7/23/20
|
Santos J, de Holanda Agostinho AY, Ferreira Soares M, et al | PROSPERO
|
|
|
7/23/20
|
Neria Espejo CA, da Silva Pedroso J, de Souza Godinho RC, et al | PROSPERO
|
|
|
7/23/20
|
Diallo A, Diallo MH | PROSPERO
|
|
|
7/23/20
|
Thompson H, Mousa A, Dighe A, et al | PROSPERO
|
|
|
7/23/20
|
Ali MM, Dahri M, Shrestha S, et al | PROSPERO
|
|
|
7/23/20
|
Bolenta MT, Khatib Z, Asamoah BO, et al | PROSPERO
|
|
|
7/23/20
|
Schmidt R, Genois R, Jin J, et al | PROSPERO
|
|
|
7/23/20
|
Glendari G, Mangkuliguna G | PROSPERO
|
|
|
7/23/20
|
Mangkulinguna G, Glendari G | PROSPERO
|
|
|
7/23/20
|
Sugita B, Marchi R, Centa A, et al | PROSPERO
|
|
|
7/23/20
|
Nurdiati D, Atthobari J, Nugroho D, et al | PROSPERO
|
|
|
7/22/20
|
Fu Y, Zihan Y, Hanzhou L, et al | PROSPERO
|
|
|
7/22/20
|
Qian K, Wang G, Peng H, et al. | Research Square
Aim: To review the evidence on the medical and clinical characteristics of the COVID-19 pandemic in China.
|
|
|
7/22/20
|
Strudwick G, Sockalingam S, Crawford A, et al. | CIHR IRSC
Aim: To review the evidence related to digital interventions that can be leveraged by the general population to support mental health during and after COVID-19.
|
|
|
7/22/20
|
Zhang T, Shui M, Zhou Y | PROSPERO
|
|
|
7/22/20
|
Puyat JH, Ahmad H, Avina M, et al. | CIHR IRSC
Aim: To investigate home-based activities that have protective and therapeutic effects against mental health symptoms during pandemics and to identify if there are activities that are effective for specific groups.
|
|
|
7/22/20
|
Arentz S, Khamba B, Mravunac M, et al | PROSPERO
|
|
|
7/22/20
|
Zhan Q, Fan XJ, Lan YQ | PROSPERO
|
|
|
7/22/20
|
Zhang T, Shui M, Zhou Y | PROSPERO
|
|
|
7/22/20
|
Maged A, Dahab S | PROSPERO
|
|
|
7/22/20
|
Hunter J, Arentz S, Goldenberg J, et al. | Integr Med Res
|
|
|
7/22/20
|
Morley S, Bollard M | PROSPERO
|
|
|
7/22/20
|
Natolanda P, Quigley A | PROSPERO
|
|
|
7/22/20
|
Resende A, Almeida IB, Gomes IA, et al | PROSPERO
|
|
|
7/22/20
|
Zhan Q, Fan XJ, Lan YQ | PROSPERO
|
|
|
7/22/20
|
Bethell J, Babineau J, Bretzlaff M, et al. | CMH Initiative
Aim: To review the evidence on social connectedness and mental health for residents of long-term care homes during the COVID-19 pandemic.
|
|
|
7/22/20
|
Zhang G, Yao X, Zhang L | PROSPERO
|
|
|
7/21/20
|
Sarfraz A, Sarfraz Z, Pervaiz Z, et al | PROSPERO
|
|
|
7/21/20
|
Khurana R, Deshpande A, Pandey N, et al | PROSPERO
|
|
|
7/21/20
|
Lim MA, Pranata R | PROSPERO
|
|
|
7/21/20
|
Kanjanabuch T, Pongpirul K, Nopsopon T, et al | PROSPERO
|
|
|
7/21/20
|
Souresrafil A, Rezapour A | PROSPERO
|
|
|
7/21/20
|
Sadeghi Z, Bahramnezhad F, Javadinejad M, et al | PROSPERO
|
|
|
7/21/20
|
Wood F, Roe T, Newman J, et al | PROSPERO
|
|
|
7/21/20
|
Zhou P, Zhao R, Zhang Y, et al | PROSPERO
|
|
|
7/21/20
|
Grimani A, Bonell C, Michie S, et al | PROSPERO
|
|
|
7/21/20
|
Aslam MS, Kim YJ, Qian L | PROSPERO
|
|
|
7/21/20
|
Dhouib W, Ayouni I | PROSPERO
|
|
|
7/21/20
|
Zhong BL | PROSPERO
|
|
|
7/21/20
|
Wang Z, Xie J, Jiang M, et al | PROSPERO
|
|
|
7/21/20
|
Hugo de Oliveira VH, de Albuquerque Filho JB, Morais de Azevedo KP, et al | PROSPERO
|
|
|
7/20/20
|
Parashar S, Karthik AR, Gupta R | PROSPERO
|
|
|
7/20/20
|
Zheng X, Li Y, Yue P, et al | PROSPERO
|
|
|
7/20/20
|
Keikha M, Kelishadi R, Akbari N, et al | PROSPERO
|
|
|
7/20/20
|
| VA Evidence Synthesis Program
VA ESP
|
|
|
7/20/20
|
| VA Evidence Synthesis Program
VA ESP
|
|
|
7/20/20
|
Hokama P, Hojama NK, Nunes-Nogueira V | PROSPERO
|
|
|
7/20/20
|
Eketunde A, Adeosun A, Lawal O, et al | PROSPERO
|
|
|
7/20/20
|
Videla A, Casetta B, Gospodinoff N, et al | PROSPERO
|
|
|
7/20/20
|
Thomas B, Pallivalapila A, El Kassem W, et al. | Syst Rev
|
|
|
7/20/20
|
Veazie S, O'Neil M, LaFavor B, et al | PROSPERO
|
|
|
7/20/20
|
Barth de Castro AC, Parlow JM, Martins CM, et al | PROSPERO
|
|
|
7/20/20
|
Esmaeili M, Abdi F, Shafiee G, et al. | Research Square
Aim: To systematically review and pool all available evidence on the olfactory and gustatory dysfunction in COVID-19 patients.
|
|
|
7/20/20
|
Li YC, Tu YK | PROSPERO
|
|
|
7/20/20
|
Wang C, Xaio S, Sun Y, et al. | Research Square
Aim: To examine the impact of respiratory infectious disease pandemics in the new millennium on mental health, behavioral responses, and parenting practices in children, and provide further intervention directions to mitigate negative effects of the 2019 novel coronavirus disease (COVID-19).
|
|
|
7/20/20
|
Zhang X, Bai H, Ji Y, et al | PROSPERO
|
|
|
7/20/20
|
Fernandez Villalobos NV, Vanella P, Lange B | PROSPERO
|
|
|
7/20/20
|
Zhang G, Qi X, An Y | PROSPERO
|
|
|
7/20/20
|
Pizarro AB, Carrasco C, Couve C, et al | PROSPERO
|
|
|
7/17/20
|
Sanderson K, Porter B | PROSPERO
|
|
|
7/17/20
|
Ozoya O, Arinze N, Adeosun A, et al | PROSPERO
|
|
|
7/17/20
|
Ali AF, Elsaid M, Tawfik GM, et al | PROSPERO
|
|
|
7/17/20
|
Zuercher SJ, Adamus C, Philipp K, et al | PROSPERO
|
|
|
7/17/20
|
Sarasmitha MS, Larasanty LPF, Chen HY | PROSPERO
|
|
|
7/16/20
|
Ramasamy A, Prithviraj M, Mohanraj PS | PROSPERO
|
|
|
7/16/20
|
Ojha V, Verma M, Pandey NN, et al | PROSPERO
|
|
|
7/16/20
|
Helvaci N, Eyupoglu ND, Karabulut E, et al | PROSPERO
|
|
|
7/16/20
|
Maitra S, Behera S, Gouri M, et al | PROSPERO
|
|
|
7/16/20
|
Williams V, Dash N, Suthar R, et al | PROSPERO
|
|
|
7/16/20
|
Hoogenes B, Queree M, Townson A, et al | PROSPERO
|
|
|
7/16/20
|
Dambha-Miller H, Albasri A, Hodgson S, et al. | BJGP Open
|
|
|
7/16/20
|
Khattab EM, Mahmoud MH, Tawfik GM, et al | PROSPERO
|
|
|
7/16/20
|
Zhu F, Zhang M, Gao M, et al. | BMJ Open
|
|
|
7/16/20
|
Zhang Q, Xu X, Sun S, et al. | Medicine
|
|
|
7/16/20
|
Liu FS, Liu J, Sun C, et al | PROSPERO
|
|
|
7/16/20
|
Chen Z, Chen X, Yu H | PROSPERO
|
|
|
7/16/20
|
Frampton L, Learmonth Y, Heritage B, et al | PROSPERO
|
|
|
7/16/20
|
Wang Y, Zhu K, Huo P, et al | PROSPERO
|
|
|
7/16/20
|
Huang K, Chang C, Shu C | Medicine
|
|
|
7/16/20
|
Reilly A, Rogers T, Bergin C, et al | PROSPERO
|
|
|
7/16/20
|
Pourdehghan P, Mostafavi SA, Mohammadi MR | PROSPERO
|
|
|
7/16/20
|
Tuina (massage) therapy for diarrhea in COVID-19: a protocol for systematic review and meta-analysis
Zhou K, Dong S, Fu G, et al | Medicine
|
|
|
7/15/20
|
Batra K, Pal Singh T, Sharma M, et al | PROSPERO
|
|
|
7/15/20
|
Rada G, Burdiles P, Quinelen E, et al | PROSPERO
|
|
|
7/15/20
|
Moody E | Dalhousie University
|
|
|
7/15/20
|
Kashour ZT, Riaz M, Garbati M, et al. | medRxiv
Aim: To systematically evaluate the effect of CQ and HCQ with or without azithromycin (AZ) on outcomes of COVID-19 patients.
|
|
|
7/15/20
|
Byambasuren O, Dobler CC, Bell K, et al. | medRxiv
Aim: To estimate the range of valid seroprevalence rates of SARS-CoV-2 in different populations, and compare these seroprevalence estimates with the cumulative cases seen in the same population.
|
|
|
7/15/20
|
Arinze N, Lawal O, Adeosun A, et al | PROSPERO
|
|
|
7/15/20
|
| CADTH
|
|
|
7/15/20
|
Shekhar R, Chourasia PK | PROSPERO
|
|
|
7/15/20
|
Gajbhiye R, Mahale S, Modi D, et al | PROSPERO
|
|
|
7/15/20
|
Matos de Abreu A, Roehrs H, Belo C, et al | PROSPERO
|
|
|
7/15/20
|
Arce S, Lai S | PROSPERO
|
|
|
7/15/20
|
Risk of sleep disturbance among medical workers during the outbreak of COVID-19: a systematic review
Labarca G, Jorquera J, Dreyse J, et al | PROSPERO
|
|
|
7/15/20
|
Silveira R, Braga F, Menegueti M, et al | PROSPERO
|
|
|
7/15/20
|
Lahiri D, Mondal R, Deb S, et al | PROSPERO
|
|
|
7/15/20
|
Sawaogo W, Haile M, Adera T | PROSPERO
|
|
|
7/15/20
|
| CADTH
|
|
|
7/15/20
|
Lin H, Du XR | PROSPERO
|
|
|
7/14/20
|
Hannah J, Ali SS, Galloway J, et al | PROSPERO
|
|
|
7/14/20
|
Sadiq F, Ain Q, Awais S, et al | PROSPERO
|
|
|
7/14/20
|
Boregowda U, Perisetti A, Nanjappa A, et al. | medRxiv
Aim: To compare the efficacy of tocilizumab in severe COVID-19 cases vs. standard of care alone.
|
|
|
7/14/20
|
Mallett S, Allen J, Graziadio S, et al. | medRxiv
Aim: To examine at what time points during SARS?CoV?2 infection it is detectable at different anatomical sites using RT?PCR based tests.
|
|
|
7/14/20
|
| CADTH
|
|
|
7/14/20
|
Misra DP, Gupta L, Chengappa KG, et al | PROSPERO
|
|
|
7/14/20
|
Prakash M, Misselwitz B, Padmanabhan S | PROSPERO
|
|
|
7/14/20
|
Melo A, Lima L, Alves B, et al | PROSPERO
|
|
|
7/14/20
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
7/14/20
|
Nutarelli S, Cuzzolin M, Filardo G, et al | PROSPERO
|
|
|
7/14/20
|
Almeda N, Garcia-Alonso CR, Salvador-Carulla L | Research Square
Aim: To identify, describe and assess the empirical background on online strategies and recommendations developed by international organizations and governments to cope with the psychological impact of COVID-19.
|
|
|
7/14/20
|
Zafra M, Valencia N, Ortiz M , et al | PROSPERO
|
|
|
7/14/20
|
Bonilla-Untiveros C, Camacho S, Baladia E, et al | PROSPERO
|
|
|
7/14/20
|
Pillay J, Hartling L, Wingert A, et al | PROSPERO
|
|
|
7/14/20
|
Aquino MRJ, Rankin J, Adamson A, et al | PROSPERO
|
|
|
7/14/20
|
| CADTH
|
|
|
7/14/20
|
Zhou X, Cheng Z, Dan S, et al | PROSPERO
|
|
|
7/14/20
|
Kaye A, Siegel R | medRxiv
Aim: To investigate and synthesize existing evidence for the efficacy of TCZ in reducing COVID-19 mortality.
|
|
|
7/14/20
|
Dhar R, Sovani M, Kulkarni T, et al | PROSPERO
|
|
|
7/14/20
|
| CADTH
|
|
|
7/13/20
|
Qu G, Shu L, Song EJ, et al. | medRxiv
Aim: To determine the true effect of ACEI/ARBs use on the risk of infection and clinical outcome of COVID-19.
|
|
|
7/13/20
|
Sarfraz A, Sarfraz Z, Zia I, et al | PROSPERO
|
|
|
7/13/20
|
Wu J, Bourouiba L, McCarthy Z, et al | PROSPERO
|
|
|
7/13/20
|
Kong X, Zhang L | PROSPERO
|
|
|
7/13/20
|
Validababy Z, Lofti M PhD | PROSPERO
|
|
|
7/13/20
|
Vascocello-Castillo L, Torres-Castro R, Alsina X, et al | PROSPERO
|
|
|
7/13/20
|
Sylvester S, Wilcox M, Nicholson S, et al | PROSPERO
|
|
|
7/13/20
|
Salifu Y, Maurer P, Oprina E, et al | PROSPERO
|
|
|
7/13/20
|
Zhou MC, Liang ZY, Wang R, et al | PROSPERO
|
|
|
7/13/20
|
Liang X, Chen C, Yang Y | PROSPERO
|
|
|
7/13/20
|
Zhou Q, Ye S | PROSPERO
|
|
|
7/12/20
|
Zaki N, Mohamed EA, Ibrahim S, et al. | Research Square
Aim: To assess how common clinical conditions and comorbidities correlate with COVID-19.
|
|
|
7/11/20
|
Subsoontorn P, Lohitnavy M, Kongkaew C | medRxiv
Aim: To determine the accuracy of nucleic acid point-of-care diagnosis for human coronavirus, particularly, SARS-CoV, MERS-CoV and SARS-CoV-2.
|
|
|
7/10/20
|
Dhar D, Mondal MS, Rutul s, et al | PROSPERO
|
|
|
7/10/20
|
Hessami A, Shamshirian A, Heydari K, et al. | medRxiv
Aim: To study cardiovascular disease burden among COVID-19 patients.
|
|
|
7/10/20
|
Lenza M, Luongo de Matos L, Marra AR, et al | PROSPERO
|
|
|
7/10/20
|
Szako L, Farkas N, Kiss S, et al | PROSPERO
|
|
|
7/10/20
|
O'Keeffe J | National Collaborating Centre for Environmental Health
|
|
|
7/10/20
|
O'Keeffe J | National Collaborating Centre for Environmental Health
|
|
|
7/10/20
|
O'Keeffe J | National Collaborating Centre for Environmental Health
|
|
|
7/10/20
|
Cai DB, Zheng W, Yuan WQ | PROSPERO
|
|
|
7/10/20
|
Santa L, Prado M, Vedovatto M, et al | PROSPERO
|
|
|
7/10/20
|
Shrestha DB, Pudhathoki P, Khadka S, et al. | Research Square
Aim: To review the efficacy and safety of favipiravir triphosphate as a treatment for COVID-19.
|
|
|
7/10/20
|
Latha T, Rao A, Bhageerathy R, et al | PROSPERO
|
|
|
7/10/20
|
Yang Y, Zhang K, Cai Z | PROSPERO
|
|
|
7/10/20
|
He B, Shen M | PROSPERO
|
|
|
7/10/20
|
Arieta-Miranda J, Alcaychahua ABS, Santos GMP, et al | PROSPERO
|
|
|
7/10/20
|
Edington F, Santiago M, Gadelha S | PROSPERO
|
|
|
7/10/20
|
Duarte Anselmi G, Ortiz-Muñoz LE, Morales Ferrer MB, et al. | OSF
|
|
|
7/10/20
|
Zace D, Hoxhaj I, Orfino A, et al | PROSPERO
|
|
|
7/10/20
|
Li G, Xu Y, Yang YT, et al. | BMJ Open
|
|
|
7/10/20
|
Guido M, Banchelli F, D'Amico R, et al | PROSPERO
|
|
|
7/9/20
|
Saha S, Saha S | PROSPERO
|
|
|
7/9/20
|
Antwi HA | Research Square
Aim: To establish the driving dynamics of healthcare in CSR engagement, identify its contribution to theory and practice and predict the future pattern as corporate enterprises navigate new CSR strategies through the epochal challenges presented by COVID-19
|
|
|
7/9/20
|
Gerogiopoulous G, Castiello T | PROSPERO
|
|
|
7/9/20
|
Wang J | PROSPERO
|
|
|
7/9/20
|
Milby K, Guedes de Melo AK | PROSPERO
|
|
|
7/9/20
|
Al Wattar BH, Zaman T, Eames S, et al | PROSPERO
|
|
|
7/9/20
|
Souza A, Linhares P, Cobucci R, et al | PROSPERO
|
|
|
7/9/20
|
Kong X, Qi Y, Fang Y, et al | PROSPERO
|
|
|
7/9/20
|
Cascino F, Hoxhaj I, Zace D, et al | PROSPERO
|
|
|
7/9/20
|
Saucedi NB, Ramos AC, Alarcon AV, et al | PROSPERO
|
|
|
7/9/20
|
Xiong X, Fritzche K, Leonhart R, et al | PROSPERO
|
|
|
7/9/20
|
Moore A, Nakahata M, Kalinich C, et al | PROSPERO
|
|
|
7/8/20
|
Prendki V, Tau N, Avni T, et al. | Research Square
Aim: To examine the participation of elderly patients in therapeutic or prophylactic trials on COVID-19.
|
|
|
7/8/20
|
Zhang B, Zhang K, Tang Q, et al. | Medicine
|
|
|
7/8/20
|
Singhal S, Kumar P, Singh S, et al. | Research Square
Aim: To review the evidence on the clinical characteristics of older COVID-19 patients.
|
|
|
7/8/20
|
Riera R, Bagattini A, Pachito D, et al | PROSPERO
|
|
|
7/8/20
|
Isaza ER, Camacho AFV, Pinilla ND, et al | PROSPERO
|
|
|
7/8/20
|
Fan W, Liu X | Medicine
|
|
|
7/8/20
|
Martins L, de Freitas Costa R | PROSPERO
|
|
|
7/8/20
|
Nearchou F, Flinn C, Hennessy E, et al | PROSPERO
|
|
|
7/8/20
|
Routhier F, Lebrasseur A, Fortin-Bedard N, et al | PROSPERO
|
|
|
7/8/20
|
Lee MH | PROSPERO
|
|
|
7/8/20
|
Alamer A | PROSPERO
|
|
|
7/8/20
|
Lowry E, Taddese H, Bowman LR | medRxiv
|
|
|
7/8/20
|
| CADTH
|
|
|
7/8/20
|
Lee MH | PROSPERO
|
|
|
7/8/20
|
Ahmed Z, Desai N | PROSPERO
|
|
|
7/8/20
|
Park R, Lee S, Kim SY, et al | PROSPERO
|
|
|
7/8/20
|
Yang Y, Zhong W, Tian Y, et al. | Medicine
|
|
|
7/8/20
|
Ow ZGW, Ng CH | PROSPERO
|
|
|
7/8/20
|
Thornton G, Zhong L, Fleck B, et al | PROSPERO
|
|
|
7/8/20
|
Almutairi E, Al-Jaffer M, Alfaifi N, et al | PROSPERO
|
|
|
7/8/20
|
Bangpan M, Kulophas D, Shi Y, et al | PROSPERO
|
|
|
7/8/20
|
Korang SK, Juul S, Nielsen EE, et al | Research Square
|
|
|
7/8/20
|
King'ori P, Mogire R, Mutua A, et al | PROSPERO
|
|
|
7/7/20
|
Pasin L, Landoni G | PROSPERO
|
|
|
7/7/20
|
Muller A | PROSPERO
|
|
|
7/7/20
|
Wu J, Zheng Y, Li L | PROSPERO
|
|
|
7/7/20
|
Meyerowitz-Katz G, Merone L | medRxiv
Aim: To review the evidence on infection-fatality rates for COVID-19.
|
|
|
7/7/20
|
Sudalaimuthu M, Sekhar S, Saravanan E | PROSPERO
|
|
|
7/7/20
|
Wang Y, Zhang Y, Liu Y, et al | PROSPERO
|
|
|
7/7/20
|
Biswas M, Kali SK | Research Square
Aim: To assess aggregated risk by investigating the association of ACEIs/ARBs users against non-users of ACEIs/ARBs with the risk of mortality or severe clinical manifestations or magnitude of SARS-CoV-2 test positivity in COVID-19 patients.
|
|
|
7/7/20
|
Zhang Z, Ai G, Chen L, et al. | Research Square
Aim: To explore the association of immunological features with COVID-19 severity.
|
|
|
7/7/20
|
Fang Z, Yi F, Wu K, et al | PROSPERO
|
|
|
7/7/20
|
Dickson K, Sutcliffe K, Bangpan M, et al | PROSPERO
|
|
|
7/7/20
|
Putera I, La Distia Nora R, Sitompul R, et al | PROSPERO
|
|
|
7/7/20
|
Souza-SIIva G, Mol M, Ceccato M, et al | PROSPERO
|
|
|
7/7/20
|
Shrestha DB, Pudhathoki P, Khadka S, et al. | Research Square
Aim: To assess the role of hydroxychloroquine with/without macrolide in terms of efficacy and adverse effects against the standard of care.
|
|
|
7/7/20
|
Dalia T, Lahan S, Ranka S, et al. | medRxiv
Aim: To delineate the influence of various cardiac conditions (especially CHF) on outcomes of patients with COVID-19 and to determine the prognostic value of cardiac biomarkers.
|
|
|
7/7/20
|
Nunes JPL | medRxiv
Aim: To perform a systematic review on mortality associated to the use of ACEi in patients with Covid 19 disease.
|
|
|
7/7/20
|
Huang J, Wu X, Lv Z | PROSPERO
|
|
|
7/7/20
|
Panda PK | PROSPERO
|
|
|
7/7/20
|
Sarti T, Lazarini WS, Fontenelle LF, et al. | medRxiv
Aim: To analyze empirical studies on the effectiveness of PHC organization strategies in the context of epidemics to improve access and reduce morbidity and mortality.
|
|
|
7/7/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/7/20
|
Hintermeier M, Bozorgmehr K, Kajikhina K, et al | PROSPERO
|
|
|
7/7/20
|
Jammu A, Chasen M, Lofters A, et al | PROSPERO
|
|
|
7/7/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/7/20
|
Whelan G, Sim J, Smith B, et al | PROSPERO
|
|
|
7/6/20
|
Sterne J, Marshall J, Diaz J, et al | PROSPERO
|
|
|
7/6/20
|
Gallo DR, Lourdes AS, Carlos R | PROSPERO
|
|
|
7/6/20
|
Pradhan RR, Yadav AK, Mandal S | Research Square
Aim: To summarize the cardiovascular implications of COVID-19.
|
|
|
7/6/20
|
Elavarasi A, Prasad M, Seth T, et al. | medRxiv
Aim: To synthesize the available data on the efficacy and safety of CQ and HCQ for the treatment of COVID-19.
|
|
|
7/6/20
|
Kumar A, Leite AF, Perrsuad P, et al | PROSPERO
|
|
|
7/6/20
|
Octavius GS, Silviani FR, Lesmanadjaja A, et al | PROSPERO
|
|
|
7/6/20
|
Souza-SIIva G, Mol M | PROSPERO
|
|
|
7/6/20
|
Fricke LM, Glockner S, Dreier M, et al | PROSPERO
|
|
|
7/6/20
|
Patralekh MK, Jain V, Iyengar K, et al | PROSPERO
|
|
|
7/6/20
|
Hannum ME, Ramirez VA, Lipson SJ, et al. | medRxiv
Aim: To provide a comprehensive assessment of methodologies currently employed to quantify smell loss in COVID-19–positive patients and examine whether method type affects reported prevalence of smell loss in COVID-19 patients.
|
|
|
7/6/20
|
Naskar C, Niyogi S | PROSPERO
|
|
|
7/6/20
|
Ssentongo P, Heilbrunn ES, Ssentongo A, et al. | medRxiv
Aim: To conduct a systematic review and meta-analysis of the prevalence of HIV in patients hospitalized for COVID-19 and delineating clinical outcomes including mortality.
|
|
|
7/6/20
|
Mondal MS, Dhar D, Dey T, et al | PROSPERO
|
|
|
7/6/20
|
Li Y, Wang P, Ding W, et al | PROSPERO
|
|
|
7/6/20
|
Anieto EM, Ogdobo V, Nwadilibe IB, et al | PROSPERO
|
|
|
7/6/20
|
Dabbagh R, Jamal A, Temsah MH, et al | PROSPERO
|
|
|
7/6/20
|
Pati S, Sahoo KC, Verma P, et al | PROSPERO
|
|
|
7/5/20
|
Chaudhari PK, Dhingra K, Zere E, et al | PROSPERO
|
|
|
7/5/20
|
Moore AJ, Nakahata MI, Kalinich CC, et al. | medRxiv
|
|
|
7/4/20
|
Muller AE, Hafstad EV, Himmels JPW, et al. | medRxiv
Aim: To identify, assess and summarize available research on the mental health impact of the covid-19 pandemic on healthcare workers.
|
|
|
7/3/20
|
Saha S, Saha S | PROSPERO
|
|
|
7/3/20
|
Landoni G, Cavalli G, Pasin L | PROSPERO
|
|
|
7/3/20
|
Starke KR, Seidler A, Seidler L | PROSPERO
|
|
|
7/3/20
|
Katagirya E, Sande O, Heilbrunn E, et al | PROSPERO
|
|
|
7/3/20
|
Acharya P, Nair D | PROSPERO
|
|
|
7/3/20
|
Meka S, Ganesh GB, Bhaskar P, et al | PROSPERO
|
|
|
7/3/20
|
Wang Y, Yuan d, Zhang H, et al | PROSPERO
|
|
|
7/3/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/3/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/3/20
|
da Silva Junior FJG, Silva Sales JCE, de Souza Monteiro CF, et al. | BMJ Open
|
|
|
7/3/20
|
Jung R, Di Santo P, Clifford C, et al. | medRxiv
Aim: To systematically evaluate the quality of reporting of currently available COVID-19 studies compared to historical controls.
|
|
|
7/3/20
|
Lant S, Civindini S, Singh B, et al | PROSPERO
|
|
|
7/3/20
|
Stockwell S, Trott M, Smith L, et al | PROSPERO
|
|
|
7/3/20
|
Arroyo-Sanchez A, Chirinos MFM, Egusquiza TM, et al | PROSPERO
|
|
|
7/3/20
|
Yoon SH, Suh YJ | PROSPERO
|
|
|
7/3/20
|
Riera R, Pacheco R, Martimbianco A, et al | PROSPERO
|
|
|
7/3/20
|
La-Rotta EG, Erazo-Chaves L, Gomez-Larrota HL, et al | PROSPERO
|
|
|
7/3/20
|
Williams M, Waterson H | PROSPERO
|
|
|
7/3/20
|
Longchamp G, Longchamp A, Blondon M, et al | PROSPERO
|
|
|
7/2/20
|
Toomey E, McSharry, Noone C | OSF
Aim: To review the evidence on accurately communicating risk to maximise adherence to public health preventive measures, while minimising negative impact on psychological outcomes (e.g. mood, mental health) within the general public.
|
|
|
7/2/20
|
Price L, Butcher J, Gozdzielewska L, Kalule A, et al | PROSPERO
|
|
|
7/2/20
|
Scquizzato T, Lembo R, Fominskiy E, et al | PROSPERO
|
|
|
7/2/20
|
Roberts A, Rogers J, Sharman S | PROSPERO
|
|
|
7/2/20
|
Samuel K, Chen K | PROSPERO
|
|
|
7/2/20
|
Gerayeli FV, Bae A, Choi L | PROSPERO
|
|
|
7/2/20
|
Tambala F, Chorwe G, Kululanga L, et al | PROSPERO
|
|
|
7/2/20
|
Zhou K, Dong S, Fu G, et al | PROSPERO
|
|
|
7/2/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/2/20
|
von Borries R, Lowe R, Soeiro D | PROSPERO
|
|
|
7/2/20
|
Sampieri C, Montero H | PROSPERO
|
|
|
7/2/20
|
Frazer K, Mitchell L, Stokes D, et al | PROSPERO
|
|
|
7/2/20
|
Gedefaw G, Demis A, Waltengus F | PROSPERO
|
|
|
7/1/20
|
Uphoff E, Lombardo C, Weeks L | PROSPERO
|
|
|
7/1/20
|
Abbas Q, Mohsin S, Khan ZA, et al | PROSPERO
|
|
|
7/1/20
|
A systematic review of deep learning-based facial recognition techniques applied in medical research
Su Z, Gelfond J, Liang B, et al | PROSPERO
|
|
|
7/1/20
|
Liu N, Li H, Zhang T, et al | PROSPERO
|
|
|
7/1/20
|
Castagne B, Emilie G, Resseguier AS, et al | PROSPERO
|
|
|
7/1/20
|
Alimoradi Z, Pakpour A | PROSPERO
|
|
|
7/1/20
|
Sharma VK, Rajak R, Tiwari S | PROSPERO
|
|
|
7/1/20
|
Zhou K, Dong S, Fu G, et al | Research Square
Aim: To summarize the current evidence of tuina (massage) used as an intervention for pulmonary function in COVID-19 recovering patients.
|
|
|
7/1/20
|
Sriwastava S, Srivastava S, Kataria S, et al. | Research Square
Aim: To study the nature and frequency of occurrence of “significant” neurological complications in coronavirus disease-2019 (COVID-19) via a systematic review of the literature.
|
|
|
7/1/20
|
Dong S, Zhou K, Fu G, et al | PROSPERO
|
|
|
7/1/20
|
Alswiahb J | PROSPERO
|
|
|
7/1/20
|
Pereira C, Vargas D | PROSPERO
|
|
|
7/1/20
|
Bragazzi NL, Watad A, Bridgewood C, et al | PROSPERO
|
|
|
7/1/20
|
Zhou Z, Zhou X, Yu H, et al | PROSPERO
|
|
|
7/1/20
|
Wang J, Yang W, Chen P, et al. | Research Square
Aim: To evaluate the proportion and efficacy of corticosteroid use for the treatment of COVID-19.
|
|
|
7/1/20
|
Dong F, Liu HL, Yang M, et al | PROSPERO
|
|
|
6/30/20
|
Yamamoto S, Saito M, Nagai H, et al | PROSPERO
|
|
|
6/30/20
|
Lee MH | PROSPERO
|
|
|
6/30/20
|
Cui L, Cheng W | PROSPERO
|
|
|
6/30/20
|
Low D | PROSPERO
|
|
|
6/30/20
|
Roberts A, Rogers J | PROSPERO
|
|
|
6/30/20
|
Ayouni I, Dhouib W, Maatoug J, et al | PROSPERO
|
|
|
6/30/20
|
Munoz O, Manes C, Alfonso P, et al | PROSPERO
|
|
|
6/30/20
|
Wang F, Pan B, Xu S, et al | PROSPERO
|
|
|
6/30/20
|
Teoh T, Munro S, Wilcox E | PROSPERO
|
|
|
6/30/20
|
Qin R, Li J | PROSPERO
|
|
|
6/30/20
|
Pellegrini L, Fineberg N, Albert U, et al | PROSPERO
|
|
|
6/30/20
|
Mingxin W, Mou R, Guo S, et al | PROSPERO
|
|
|
6/30/20
|
Khadka S, Budhathoki P, Shrestha DB, et al. | Research Square
Aim: To evaluate the outcome and potential harmful cardiac effects of AZT+HCQ compared to HCQ alone for COVID-19 treatment.
|
|
|
6/30/20
|
Chen L, An S, Yao G, et al. | Research Square
Aim: To provide a systematic review of the literature and meta-analysis on the use of HCQ/CQ with respect to safety and clinical efficacy of these medications.
|
|
|
6/30/20
|
Hu X-Y, Zhang XW, Zheng RX, et al | PROSPERO
|
|
|
6/30/20
|
Su Z, Wang J, Li X, et al | PROSPERO
|
|
|
6/30/20
|
de Melo Monteiro GQ, Leonidas Gomes AS, Paz Alvarenga MO, et al | PROSPERO
|
|
|
6/30/20
|
Li R, Li Y, Sun H, et al | PROSPERO
|
|
|
6/30/20
|
Sadhu S, Dandapani SA, Mazumdar D, et al. | medRxiv
Aim: To estimate the prevalence of ocular manifestations and ocular samples polymerase chain reaction (PCR) positivity among COVID 19 patients.
|
|
|
6/30/20
|
Bartlett C, Garlovsky J | PROSPERO
|
|
|
6/30/20
|
Ruiyu M, Li X, Guo S, et al | PROSPERO
|
|
|
6/30/20
|
Kpozehouen E, Macintyre R, Tan T | PROSPERO
|
|
|
6/30/20
|
Brainard J, Harrison F, Jones N, et al | PROSPERO
|
|
|
6/30/20
|
da Costa KVT, Carnauba ATL, Rocha KW, et al. | Research Square
Aim: To conduct a systematic review with meta-analysis on the treatments for post-viral non-conductive olfactory disorder (NCSD) to be proposed for olfactory disorder in COVID-19.
|
|
|
6/29/20
|
Weeks L, Stilwell C, Rothfus M, et al | PROSPERO
|
|
|
6/29/20
|
Wood S, Vaughan M, Pardhan S | PROSPERO
|
|
|
6/29/20
|
Wood S, Vaughan M, Pardhan S | PROSPERO
|
|
|
6/29/20
|
Soeroto AY, Soetedjo NN, Purwiga A, et al. | medRxiv
Aim: To evaluate the association between obesity and composite poor outcome in coronavirus disease 2019 (COVID-19) patients.
|
|
|
6/29/20
|
Jacob S, Hammed A, Pang T, et al | PROSPERO
|
|
|
6/29/20
|
Schwartzberg L, Lin A, Jorizzo J | PROSPERO
|
|
|
6/29/20
|
Elsawah H, Elrazzaz M, Hany A | PROSPERO
|
|
|
6/29/20
|
Johanna N, Henrico -, Wangge G | PROSPERO
|
|
|
6/29/20
|
Sehmi P, Cheruiyot I | medRxiv
Aim: To systematically analyze literature to establish any evidence of live SARS-CoV-2 virus in fecal samples of COVID-19 patients.
|
|
|
6/29/20
|
Ruiyu M, Xinyao J, Shanqi G | PROSPERO
|
|
|
6/29/20
|
Buzzachera CF, Bernardes AG, Correale L | PROSPERO
|
|
|
6/29/20
|
Demis A, Getie A, Gedefaw G, et al | PROSPERO
|
|
|
6/29/20
|
Chen M, Qin R | PROSPERO
|
|
|
6/29/20
|
Zha L, Xu Q, Oan L, et al | PROSPERO
|
|
|
6/29/20
|
Lee MH | PROSPERO
|
|
|
6/29/20
|
Deng J | PROSPERO
|
|
|
6/29/20
|
Emami A, Javanmardi F | PROSPERO
|
|
|
6/29/20
|
Kelada M, Dave K, Anto A | PROSPERO
|
|
|
6/26/20
|
Wilson P, Islam J, Weinbren M, et al | PROSPERO
|
|
|
6/26/20
|
Bak A, Wilson P, Islam J, et al | PROSPERO
|
|
|
6/26/20
|
Bansal A, Singh AD, Jain V, et al. | medRxiv
Aim: To determine if the d-dimer levels are elevated in individuals with COVID 19 having worse clinical outcomes including all-cause mortality, ICU admission or ARDS.
|
|
|
6/26/20
|
Bloomer M, Walshe C | PROSPERO
|
|
|
6/26/20
|
Purohit P, Tomo S, Kumar PVSN, et al | PROSPERO
|
|
|
6/26/20
|
Wang M, Zheng H, Wang X, et al | PROSPERO
|
|
|
6/26/20
|
Peters A, Lotfinejad N, Palomo R | PROSPERO
|
|
|
6/26/20
|
| CADTH
|
|
|
6/26/20
|
Rezapour A, Souresrafil A | PROSPERO
|
|
|
6/26/20
|
Li J, Liao X, Zhou Y, et al | PROSPERO
|
|
|
6/26/20
|
Braga M, Machado G, Raggio DP, et al | PROSPERO
|
|
|
6/26/20
|
Mondal R, Ganguly U, Deb S, et al. | medRxiv
Aim: To summarise the clinical profile, investigations and radiological findings among patients with SARS-CoV-2 associated meningoencephalitis.
|
|
|
6/25/20
|
Innes N, Gallagher J, Harris R, et al. | PROSPERO
|
|
|
6/25/20
|
Christina Savvides, Siegel R | PROSPERO
|
|
|
6/25/20
|
Kuan PX, Chan WK, Ooi MH | PROSPERO
|
|
|
6/25/20
|
Putera D, Gofi A, Wibowo | PROSPERO
|
|
|
6/25/20
|
Scattone De Luiz L, Carneiro LG, et al. | PROSPERO
|
|
|
6/25/20
|
Stansfield J, Dobbs S, Ghosh S | PROSPERO
|
|
|
6/25/20
|
Khan M, Ostlundh L, Karuveetil P, et al | PROSPERO
|
|
|
6/25/20
|
Correa C, Franca M, Santos E, et al. | PROSPERO
|
|
|
6/25/20
|
Al-Moraissi E, Alyahya A | PROSPERO
|
|
|
6/25/20
|
Bhagavathula AS, Aldhaleei WA | medRxiv
Aim: To summarize the level of KAP about COVID-19 via a systematic review.
|
|
|
6/25/20
|
Porto EF, Iamonti VC, de Castro AAM, et al. | Research Square
Aim: To carry out a systematic review of what has been published so far on mortality in patients with COVID-19 associated with diabetes comorbidity.
|
|
|
6/25/20
|
Gedefaw G, Demis A, Waltengus F | PROSPERO
|
|
|
6/25/20
|
Dong S, Zhou K, Guo S, et al. | PROSPERO
|
|
|
6/25/20
|
Lira Neto JCG | PROSPERO
|
|
|
6/25/20
|
Lozano-Lozano M, Lopez-Garzon M, Gonzalez-Santos A, et al. | PROSPERO
|
|
|
6/25/20
|
Diniz dos Reis P, Barros Ferreira E, Silva Guerra EN, et al. | PROSPERO
|
|
|
6/25/20
|
Qiu D, Yan Q, Hu Y, et al. | PROSPERO
|
|
|
6/25/20
|
Roethke N, Guenthner L, Stoffers-Winterling J, et al. | PROSPERO
|
|
|
6/25/20
|
Monsalves MJ, Zuniga B, Saavedra JA, et al. | PROSPERO
|
|
|
6/25/20
|
Vindrola C, Kesser C, Vera N, et al. | PROSPERO
|
|
|
6/25/20
|
Aloona S, Chauhan CK, Mohindra R, et al. | PROSPERO
|
|
|
6/24/20
|
Pearce L, Feirrera LC, Foulds J, et al | PROSPERO
|
|
|
6/24/20
|
Reddy MP, Subramaniam A, Lim ZJ, et al | PROSPERO
|
|
|
6/24/20
|
Su Z | PROSPERO
|
|
|
6/24/20
|
Tibubos AN, Ernst M, Otten D | PROSPERO
|
|
|
6/24/20
|
Agarwal L, Agarwal A, Madhusudhan KS, et al | PROSPERO
|
|
|
6/24/20
|
Salah HM, Candales AL | Research Square
Aim: To examine the current prevalence and mortality of ACI among COVID-19 infected patients.
|
|
|
6/24/20
|
De Leon Jr. R, Allegrante JP, Kita | PROSPERO
|
|
|
6/24/20
|
Nasajpour A, Raina JS, Itare VB, et al | PROSPERO
|
|
|
6/24/20
|
Su Q, Hu J, Lin H, et al. | medRxiv
Aim: To examine the prevalence of cancer among patients with COVID-19 infection and their risks of severe events.
|
|
|
6/24/20
|
Hulme C, Ebell M, Bentivegna M, et al | PROSPERO
|
|
|
6/24/20
|
Chen Y, Chen L | PROSPERO
|
|
|
6/24/20
|
Cai J, Yang X, Li G, et al | PROSPERO
|
|
|
6/23/20
|
Patil V, Khunti K, Seidu S, et al | PROSPERO
|
|
|
6/23/20
|
Vasco S, Herrera A, Verdesoto C, et al | PROSPERO
|
|
|
6/23/20
|
Roshdy A, Zaher S | PROSPERO
|
|
|
6/23/20
|
Ismail S, van Schalkwyk M, Eddy D, et al | PROSPERO
|
|
|
6/23/20
|
Karam M, Althuwaikh S, Alazemi M, et al. | medRxiv
Aim: To compare the performance of chest computed tomography (CT) scan versus reverse transcription polymerase chain reaction (RT-PCR) in the initial diagnostic assessment of coronavirus disease 2019 (COVID-19) patients.
|
|
|
6/23/20
|
Chen H, Xie Z, Zhu Y, et al. | Medicine
|
|
|
6/23/20
|
Carmisciano L, Signori A | OSF Registries
|
|
|
6/23/20
|
| Cochrane COVID Rapid Reviews
|
|
|
6/23/20
|
Chan V, Leow J, Tan WS, et al | PROSPERO
|
|
|
6/23/20
|
Lu Z, Lu M, Cao Z | Medicine
|
|
|
6/23/20
|
Ciswaka H, Hyute F, Mupungu N, et al | PROSPERO
|
|
|
6/23/20
|
Li J, Liao X, Wang L, et al | PROSPERO
|
|
|
6/23/20
|
Predergast N, Shah F, Price C, et al | PROSPERO
|
|
|
6/23/20
|
Billings J, Ching B, Gkofa V, et al. | medRxiv
Aim: To provide a rapid review and meta-synthesis of qualitative literature describing healthcare workers’ experiences of working on the frontline and their views about psychosocial support, during Covid-19 or comparable pandemics, such as SARS, MERS or Ebola.
|
|
|
6/23/20
|
Tian H, Xue Y, Yao RR, et al | PROSPERO
|
|
|
6/23/20
|
Chen X, Laurent S, Onur O, et al | Research Square
Aim: To study the frequency of neurological symptoms and complications in COVID-19 patients in a systematic review of the literature.
|
|
|
6/23/20
|
| CADTH
|
|
|
6/23/20
|
Ortiz-Muñoz L, Morales Ferrer M, Duarte-Anselmi G, et al. | OSF Preprints
Aim: To provide a summary of the evidence available on the the efficacy of the use of gloves in the prevention of COVID-19 disease in healthy population.
|
|
|
6/23/20
|
Waring S, Giles S | PROSPERO
|
|
|
6/23/20
|
Craxford S, Marson B, Rollins K, et al | PROSPERO
|
|
|
6/23/20
|
Chen M, Zhu H | PROSPERO
|
|
|
6/23/20
|
Mahat RK, Panda S, Vedika R, et al | PROSPERO
|
|
|
6/23/20
|
Chaufan C, Yousefi N | PROSPERO
|
|
|
6/23/20
|
Liu M, Zhu H, Zhu Y, et al | PROSPERO
|
|
|
6/23/20
|
Hou Y, Jia Z | PROSPERO
|
|
|
6/23/20
|
Martinez-Salas A, Navarro-Ruesga I, Muruato-Araiza S, et al | PROSPERO
|
|
|
6/23/20
|
Sinclair JE, Zhu Y, Xu G, et al. | medRxiv
Aim: To analyse the role of pre-existing chronic disease (chronic respiratory illness, cardiovascular disease (CVD), hypertension and diabetes mellitus) in the development of cardiac complications from SARS-CoV-2.
|
|
|
6/23/20
|
Ramanathan K, Brodie D, Fan E, et al | PROSPERO
|
|
|
6/23/20
|
Clive A, Lalor JG, Ohaja M, et al | PROSPERO
|
|
|
6/22/20
|
Upshur R, Sud A, Salamanca-Buentello F, et al. | CMH Initiative
Aim: To review the evidence on the impact of major medical disruptions such as natural disasters or human conflicts on opioid substitution therapy.
|
|
|
6/22/20
|
Hatcher S, Zortea T, Brenna C, et al. | CIHR IRSC
Aim: To review the evidence on suicide prevention initatives during the COVID-19 pandemic.
|
|
|
6/22/20
|
Reichelt AJ, da Rocha Oppermann ML, Genro VK, et al | PROSPERO
|
|
|
6/22/20
|
Mahmoud I, Alkundi A, Mahdi A | PROSPERO
|
|
|
6/22/20
|
Wei Y, Wei L, Liu Y, et al. | medRxiv
Aim: To estimate the central tendency and dispersion for incubation period of COVID-19 and, in turn, assess the effect of a certain length of quarantine for close contacts in active monitoring.
|
|
|
6/22/20
|
Traore I, Nabe AB, Sylla AS, et al | PROSPERO
|
|
|
6/22/20
|
Rodgers A, Indreberg EK, Alfallaj L, et al. | medRxiv
Aim: To review the evidence on the impact of smoking on the intensity of COVID-19 clinical manifestations.
|
|
|
6/22/20
|
Mahat RK, Rathore V, Panda S, et al | PROSPERO
|
|
|
6/22/20
|
Bashir N, Sharma P | PROSPERO
|
|
|
6/22/20
|
Desai N, Young B, Nair G, et al | PROSPERO
|
|
|
6/22/20
|
Lane EA, Barrett DJ, Casey M, et al. | medRxiv
Aim: To evaluate the available literature, to consider parameters affecting hospital resources, to effectively guide health policy and planning.
|
|
|
6/22/20
|
Bhat V, Blumberger D, Flint A, et al. | CIHR IRSC
Aim: To review the evidence on offering procedural interventions (ECT and rTMS) for at-risk populations in psychiatry during the COVID-19 pandemic.
|
|
|
6/22/20
|
Liu Y, Bell K, Wong G, et al | PROSPERO
|
|
|
6/22/20
|
Hijazi K, Lawes T, Wilson B, et al | PROSPERO
|
|
|
6/22/20
|
Raja M, Shafiq M, Jamil B, et al | PROSPERO
|
|
|
6/22/20
|
Gagnon M, LeBlanc A, Sasseville M, et al. | CIHR IRSC
Aim: To review the evidence on digital health interventions to prevent, detect and manage mental health problems in individuals with chronic disease in the context of the COVID-19 pandemic.
|
|
|
6/22/20
|
Quilty LC, Agic B, Buckley L, et al. | CIHR IRSC
Aim: To review the digital health resources for addiction in Canada and the degree to which they incorporate principles of gender- and trauma-informed care.
|
|
|
6/22/20
|
Pegorari MS, Ohara DG, Matos AP, et al | PROSPERO
|
|
|
6/22/20
|
Diaz LA, Candia R, Cannistra M, et al | PROSPERO
|
|
|
6/22/20
|
Meherali S, Lassi Z, Das J, et al. | CIHR IRSC
Aim: To review the evidence on mental health and substance use among children and adolescents amidst COVID-19.
|
|
|
6/22/20
|
Flynn M, Dooley J | PROSPERO
|
|
|
6/22/20
|
Darley S, Coulson T, Peek N, et al | PROSPERO
|
|
|
6/22/20
|
Abraham S, Ramkisson R, Mahalingappa S, et al | PROSPERO
|
|
|
6/22/20
|
Abdul-Mumin KH, Idris DR, Rahman HA, et al | PROSPERO
|
|
|
6/22/20
|
Larney S, Bruneau J, Raynault MF, et al | CMH Initiative
Aim: To review the evidence on "Big Events" with relevance to the COVID-19 pandemic to assess the impacts on risk behaviors and drug-related harms among people who use drugs, and the delivery of harm reduction and drug treatment services.
|
|
|
6/22/20
|
Dzinamarira T, Mhango M, Ngara B, et al | PROSPERO
|
|
|
6/22/20
|
Irfan O, Tang K, Li Jiang, et al | PROSPERO
|
|
|
6/22/20
|
Okita Y, Morita T | PROSPERO
|
|
|
6/22/20
|
Souresrafil A, Rezapour A | PROSPERO
|
|
|
6/22/20
|
MacDermid J, Bobos P, Nazari G | CIHR IRSC
Aim: To evaluate the effectiveness of virtual biopsychosocial interventions in comparison to sham, traditional, or alternative virtual treatments in these patients using a network analysis approach.
|
|
|
6/22/20
|
Rohini C, Munshi H, Chacko S, et al | PROSPERO
|
|
|
6/22/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/22/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/22/20
|
Milne L, Reid N, Prado S, et al. | Canadian Institutes for Health Research
Aim: To review the evidence on child welfare across the Canadian Prairies during the COVID-19 pandemic.
|
|
|
6/22/20
|
Christophers B | OSF Registries
|
|
|
6/22/20
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
6/22/20
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
6/20/20
|
Stamm TA, Andrews MR, Mosor E, et al. | medRxiv
Aim: To review clinical practice guidelines and recommendations in the context of COVID-19 to explore if basic methodological standards of guideline development have been met.
|
|
|
6/20/20
|
Dorjee K, Kim H | medRxiv
Aim: To summarize the prevalence adverse outcomes, risk factors, and association of risk factors with adverse outcomes in COVID-19 patients.
|
|
|
6/19/20
|
Yigezu A, Mirkuzie A, Mengistu M | PROSPERO
|
|
|
6/19/20
|
Handley M, Bunn F, Goodman C, et al | PROSPERO
|
|
|
6/19/20
|
Su Z | PROSPERO
|
|
|
6/19/20
|
Abraham G, Yitbarek K, Beshea G | PROSPERO
|
|
|
6/19/20
|
Kim M, An M, Kim W, et al. | medRxiv
Aim: To evaluate the comparative efficacy and safety of pharmacological interventions used in treating COVID-19 and form a basis for an evidence-based guideline of COVID-19 management by evaluating the level of evidence behind each treatment regimen in different clinical settings.
|
|
|
6/19/20
|
Matuoka J, Oliveira Jr. H, Parreira P, et al | PROSPERO
|
|
|
6/19/20
|
Bradley D, Miller S, Dempster M | PROSPERO
|
|
|
6/19/20
|
Bakhit M, Krzyzaniak N, Scott A, et al. | medRxiv
Aim: To identify, appraise, and synthesise studies evaluating the downsides of wearing facemasks in any setting.
|
|
|
6/19/20
|
Tobaiqy M, Alhumaid S, Al Mutair A | medRxiv
Aim: To assess the efficacy and safety of lopinavir/ritonavir in COVID-19 patients in the extant published research.
|
|
|
6/19/20
|
Negoi I, Maeda Y, Hostiuc S | PROSPERO
|
|
|
6/19/20
|
Fonria ES, Vigo MI, Garcia-Garcia D, et al. | medRxiv
Aim: To identify and summarize the key epidemiological parameters used so far for mathematical modeling and clinical purposes.
|
|
|
6/19/20
|
Kumar G, Singh N, Dhillon JD | PROSPERO
|
|
|
6/19/20
|
Fiolet T, Guihur A, Rebeaud M, et al. | medRxiv
Aim: To bring a new overview on this controversial drug and to assess whether hydroxychloroquine could reduce COVID-19 mortality risk in hospitalized patients.
|
|
|
6/19/20
|
Tamuzi JL, Birhanu AT, Shumba CS, et al. | Research Square
Aim: To review different studies on SARS-CoV, MERS-CoV or COVID-19 associated with HIV/TB co-infection or only TB and to understand the interactions between HIV, TB and COVID-19 and its implications on the burden of the COVID-19 among HIV/TB co-infected or TB patients, screening algorithm and clinical management.
|
|
|
6/19/20
|
Flook M, Jackson C, Vasileiou E, et al. | Research Square
Aim: To present the current status of scientific knowledge in these areas and describe the need for unified global approaches, moving forwards, as well as lessons learnt for future pandemics.
|
|
|
6/19/20
|
Menon GR, John D, Adhikari T, et al | PROSPERO
|
|
|
6/19/20
|
Kaur H, Thakur JS, Paika R | PROSPERO
|
|
|
6/19/20
|
Arshad U, Ejaz S, ul-Ain F, et al | PROSPERO
|
|
|
6/19/20
|
Plancencia DR, Perez AR, Diaz LA, et al | PROSPERO
|
|
|
6/19/20
|
Liu C, Li B, Pan W, et al | PROSPERO
|
|
|
6/19/20
|
Pegorari MS, Ohara SG, Matos AP, et al | PROSPERO
|
|
|
6/19/20
|
Bhoelan S, Meijer K, Codreanu C | PROSPERO
|
|
|
6/19/20
|
Acharya P, Nair D | PROSPERO
|
|
|
6/19/20
|
Hu Y, Zhang F, Sheng X, et al | PROSPERO
|
|
|
6/19/20
|
Xu J, Shang L, Teng Y, et al | PROSPERO
|
|
|
6/19/20
|
Deng L, Zhang Q, Fan YH | PROSPERO
|
|
|
6/19/20
|
Chen H, Guo Z, Xiang S | PROSPERO
|
|
|
6/19/20
|
Ayers C, Kondo K, Saha S, et al | VA Evidence Synthesis Program
VA ESP
|
|
|
6/19/20
|
Glasbey J, Trout I, Bhangu A, et al | PROSPERO
|
|
|
6/18/20
|
Chung S, Marlow S, Tobias N, et al. | medRxiv
Aim: To conduct a rapid review on the efficacy and policy of contact tracing, testing, and isolation (TTI) in Covid-19 prevention and control, including a case study for their delivery.
|
|
|
6/18/20
|
Savvides C, Siegel R | medRxiv
Aim: To discuss the literature of asymptomatic and presymptomatic transmission, highlight limitations of recent studies, and propose experiments that, if conducted, would provide a more definitive analysis of the relative role of presymptomatic and asymptomatic transmission in the ongoing SARS-CoV-2 pandemic.
|
|
|
6/18/20
|
Whittaker C, Mousa A | PROSPERO
|
|
|
6/18/20
|
Rajendran K, Murugan N, Krishnasamy N, et al | PROSPERO
|
|
|
6/18/20
|
Kharvi RK, Padmashali S, Poojary S, et al | PROSPERO
|
|
|
6/18/20
|
Singh S, Khera D, Chugh A, et al | PROSPERO
|
|
|
6/18/20
|
Lomardo P, Nunes M, Casado P, et al | PROSPERO
|
|
|
6/18/20
|
Boltena MT, Kebede AS, Shargie MB, et al | PROSPERO
|
|
|
6/18/20
|
Campos Espinoza RE, Rodriguez Talledo CR | PROSPERO
|
|
|
6/18/20
|
Nora VD, Azevedo N, Rosa D | PROSPERO
|
|
|
6/18/20
|
Su Y, Guo L, Ma M, et al | PROSPERO
|
|
|
6/18/20
|
Tleyjeh I, Kashour Z, Al Dosary O, et al. | medRxiv
Aim: To systematically review the literature and estimate the risk of cardiac toxicity in patients receiving CQ or HCQ for COVID-19.
|
|
|
6/18/20
|
Campos Espinoza RE, Rodriguez Talledo CR | PROSPERO
|
|
|
6/18/20
|
Bansal A, Kumar A, Maheshwari R, et al | PROSPERO
|
|
|
6/18/20
|
Damiano RF, Lucchetti G, Miguel Filho EC | PROSPERO
|
|
|
6/18/20
|
Garroz R, Martinez P, Camacho S, et al | PROSPERO
|
|
|
6/17/20
|
Traore I, Nabe AB, Sylla AS, et al | PROSPERO
|
|
|
6/17/20
|
Langford B, Leung V, So M, et al | PROSPERO
|
|
|
6/17/20
|
Zhu Y, Huang H, Li W, et al. | Medicine
|
|
|
6/17/20
|
Budhathoki P, Shrestha DB, Rawal E, et al. | Research Square
Aim: To assess the rationality on the use of corticosteroids in COVID-19.
|
|
|
6/17/20
|
Chen H, Yanping S, Kai G, et al. | Medicine
|
|
|
6/17/20
|
Rankin J, Slack E, Glinianaia S | PROSPERO
|
|
|
6/17/20
|
de Albuquerque Figueiredo S, Egito L, Melo L | PROSPERO
|
|
|
6/17/20
|
von Vartheld CS, Hagen MM, Butowt R | medRxiv
Aim: To gain a more comprehensive and conclusive account of the prevalence of chemosensory deficits in COVID-19.
|
|
|
6/17/20
|
Khanijahani A, Gholipour K, Azami-Aghdash S, et al. | Research Square
|
|
|
6/17/20
|
Deng L, Zhang Q, Fan YH | PROSPERO
|
|
|
6/17/20
|
Zhang Q, Cao F, Wang Y, et al. | Medicine
|
|
|
6/17/20
|
The safety Usage of RAAS Inhibitor Drugs in COVID-19 Patients: A Systematic Review and Meta-Analysis
Hariyanto TI, Japar KV, Damay V, et al | PROSPERO
|
|
|
6/17/20
|
Mathioudakis A, Fally M, Felton T, et al | PROSPERO
|
|
|
6/16/20
|
Mensah KB, Mensah ABB, Bangalee VB, et al. | medRxiv
Aim: To gather evidence on antiviral activity and possible mechanism of drug action of chloroquine and hydroxychloroquine on SARS-CoV-2, including in-vitro, animal studies, and studies in humans.
|
|
|
6/16/20
|
De Rosa S, Indolfi C, Di Salvo G, et al | PROSPERO
|
|
|
6/16/20
|
Henrina J, Putra ICS, Cahyadi I, et al. | medRxiv
Aim: To investigate the clinical characteristics and outcomes of Coronavirus Disease of 2019 (COVID-19) patients complicated with venous thromboembolism (VTE).
|
|
|
6/16/20
|
Khera D, Singh S, Chugh A, et al | PROSPERO
|
|
|
6/16/20
|
Ravi R, Gunjawate DR, Kumar B R, Verma A | PROSPERO
|
|
|
6/16/20
|
Vakili K, Fathi M, Sayehmiri F, et al. | medRxiv
Aim: To evaluate the prevalence of most common symptoms and complications of COVID-19.
|
|
|
6/16/20
|
Regmi K, Lwin CM | medRxiv
|
|
|
6/16/20
|
| CADTH
|
|
|
6/16/20
|
Roshanshad A, Kamalipour A, Ashraf MA, et al. | medRxiv
Aim: To investigate the latest clinical evidence on the treatment efficacy and safety of Remdesivir in hospitalized patients with COVID-19.
|
|
|
6/16/20
|
Samaranayake L, Fakhruddin K, Panduwawala C | Preprints
Aim: To evaluate the contemporary evidence on dysgeusia and anosmia as trigger symptoms in COVID-19.
|
|
|
6/16/20
|
Ssentongo A, Heilbrunn E, Ssentongo P, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Deng J, Zhou F, Chang O, et al | PROSPERO
|
|
|
6/16/20
|
Obi O, Odoh D | PROSPERO
|
|
|
6/15/20
|
Doustmohammadian A, Afshar L, Kasaii MS, | PROSPERO
|
|
|
6/15/20
|
Splig E, Shea B, Rushton C, et al | PROSPERO
|
|
|
6/15/20
|
Naimi-Akbar A, Tranæus S, Klinge B, et al | PROSPERO
|
|
|
6/15/20
|
Juneau C, Pueyo T, Bell M, et al. | medRxiv
Aim: To provide a comprehensive summary of the evidence on epidemic control, with a focus on cost-effectiveness.
|
|
|
6/15/20
|
Wang J, Cui H, Tang H | Research Square
Aim: To understand the clinical manifestations and incidence of gastrointestinal symptoms of Coronavirus disease (COVID-19) in children and discuss the importance of fecal nucleic acid testing.
|
|
|
6/15/20
|
Sahu A, Sureshbabu S, Mathew R | PROSPERO
|
|
|
6/15/20
|
Currie C, Larouche R, Voss L , et al | PROSPERO
|
|
|
6/15/20
|
Wei Y, Liu Y, Huang L, et al | PROSPERO
|
|
|
6/15/20
|
Mekuria AN, Edessa D, Hagos B | PROSPERO
|
|
|
6/15/20
|
Costenaro P, Chiara Minotti C, Barbieri E, et al | PROSPERO
|
|
|
6/15/20
|
Tamara A, Simadibrata DM, Pandhita BA, et al | PROSPERO
|
|
|
6/15/20
|
Irfan O, Sajid I, Tang K | PROSPERO
|
|
|
6/15/20
|
Mekuria AN, Edessa D, Hagos B | PROSPERO
|
|
|
6/15/20
|
Zhang L, Peng J, Lou W, et al | PROSPERO
|
|
|
6/15/20
|
Chen C, Tan G, Liang X, et al | PROSPERO
|
|
|
6/15/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
|
|
|
6/15/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
|
|
|
6/15/20
|
Chan CK, Huang YS, Liao HW, et al | PROSPERO
|
|
|
6/15/20
|
Harling M, Pearce-Smith N, Clark R, et al | PROSPERO
|
|
|
6/14/20
|
Almeshari M, Alobaidi N, Al Asmri M, et al. | medRxiv
Aim: To provide insight into the initial IMV practices for COVID-19 patients in the initial phase of the pandemic.
|
|
|
6/12/20
|
Khan Z, Park S, Black G, et al | PROSPERO
|
|
|
6/12/20
|
Kates A, Mapes A, Godredy J, et al | PROSPERO
|
|
|
6/12/20
|
Kaur A, Cubitt J, Hemington-Gorse S, Sin-Hidge C | PROSPERO
|
|
|
6/12/20
|
Su Z, Wang J, Meyer K, et al | PROSPERO
|
|
|
6/12/20
|
Li F, Lu H, Wang X, et al | PROSPERO
|
|
|
6/12/20
|
Zhang Q, Lu H, Li F, et al | PROSPERO
|
|
|
6/12/20
|
Chisale M, Kalasa J, Watson F, et al | PROSPERO
|
|
|
6/12/20
|
Bwire GM, Njiro BJ | medRxiv
Aim: To determine the immunoglobulin G and M (IgG/IgM) levels among infants born to mothers with COVID-19.
|
|
|
6/12/20
|
Xiao Q, Zhang Y, Li J, Zhong D, et al | PROSPERO
|
|
|
6/12/20
|
Moreira J, Nzwalo H, Moreira P | PROSPERO
|
|
|
6/12/20
|
Alinaitwe B, Ngabirano T, Kato C, et al | PROSPERO
|
|
|
6/12/20
|
Li H, Su S, Zheng Y | PROSPERO
|
|
|
6/12/20
|
de Lima Silva V, de Sales Coriolano M, de Mello A, et al | PROSPERO
|
|
|
6/12/20
|
Hughes S, Carle C, Campbell D, et al | PROSPERO
|
|
|
6/12/20
|
Wang J, Tang H | PROSPERO
|
|
|
6/12/20
|
Scaffidi M, Gimpaya N, Bansal R, et al | PROSPERO
|
|
|
6/12/20
|
Ortega KL, Rech B, Sayans MP, et al | PROSPERO
|
|
|
6/12/20
|
Mistry N, Gosavi S, Kerde P | PROSPERO
|
|
|
6/12/20
|
Kefale B, Temesgen G, Tesfa D, et al | PROSPERO
|
|
|
6/12/20
|
AbuMweis S, Alzoughool F, AlAnagreh L, et al | PROSPERO
|
|
|
6/12/20
|
Zamuner AR, Bustos-Moyano O, Molina-Gutierrez N | PROSPERO
|
|
|
6/12/20
|
Fathi M, Vakili K, Sayehmiri F, et al. | medRxiv
Aim: To provide additional data regarding the clinical characteristics of patients diagnosed with COVID-19 and in particular to analyze the factors associated with disease severity, unimprovement and mortality.
|
|
|
6/12/20
|
Kumar M, Mittal M, Mohan K, et al | PROSPERO
|
|
|
6/12/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
|
|
|
6/12/20
|
Hughes S, Carle C, Campbell D, et al | PROSPERO
|
|
|
6/12/20
|
Rafferty A, Hughes W, Bofkin K, et al | PROSPERO
|
|
|
6/11/20
|
A living systematic review and cumulative meta-analysis of herbal medicine intervention for COVID-19
Ang L, Soo Lee M, Song E, et al | PROSPERO
|
|
|
6/11/20
|
Jiang Y, Chen D, Cai D, et al | PROSPERO
|
|
|
6/11/20
|
Driggs D, Etmann C, Gilbey J, et al | PROSPERO
|
|
|
6/11/20
|
Jayant K, Shapiro J, Reccia I | PROSPERO
|
|
|
6/11/20
|
Kandil O, Amin E, Youssef B, et al | PROSPERO
|
|
|
6/11/20
|
Zhang T, Ma L, Li H, et al | PROSPERO
|
|
|
6/11/20
|
Wieland LS, Piechotta V, Feinberg T, et al | PROSPERO
|
|
|
6/11/20
|
Keshtkar AA, Safarpour AR, Pourahmadi M, et al | PROSPERO
|
|
|
6/11/20
|
Dolci G, Cassone G, Costantini M, et al | PROSPERO
|
|
|
6/11/20
|
Liu LP, Li J, Zong SY | PROSPERO
|
|
|
6/11/20
|
Munoz-Ortiz L, Pizarro AB, Baladia E, et al | PROSPERO
|
|
|
6/11/20
|
Cakaloz DK, Ozturk G, Karacam Z, et al | PROSPERO
|
|
|
6/11/20
|
Moreira A, Ahmed M, Moreira A | PROSPERO
|
|
|
6/11/20
|
Costa D, Melo P | PROSPERO
|
|
|
6/11/20
|
Alkhathami M, Al Shehri M, Al Salamah J, et al. | medRxiv
Aim: To determine the prelavence and mortality of chronic lung diseases which include COPD, lung cancer, asthma, and cystic fibrosis in confirmed COVID-19 cases.
|
|
|
6/11/20
|
Hartley A, Howard J, Jabbour R | PROSPERO
|
|
|
6/11/20
|
Nopp S, Moik F, Ay C | PROSPERO
|
|
|
6/11/20
|
Punjwani Z | Centre for Studies in Aging and Health
|
|
|
6/11/20
|
Gong X, Lv M, Wang J, et al | PROSPERO
|
|
|
6/11/20
|
Mapanga W, Girdler-Brown, Murray J | PROSPERO
|
|
|
6/11/20
|
Gong X, Liang S, Lv M, et al | PROSPERO
|
|
|
6/11/20
|
Tomas I, Balsa C | PROSPERO
|
|
|
6/10/20
|
McDonald I, Reynolds C, Boyton R, et al | PROSPERO
|
|
|
6/10/20
|
Tesfaye W, Bezabh S, Erku D, et al | PROSPERO
|
|
|
6/10/20
|
Du P, Luo X | PROSPERO
|
|
|
6/10/20
|
Asiimwe IG, Pushpakom S, Turner R, et al | PROSPERO
|
|
|
6/10/20
|
Zi H, Wang Y, Wang N, et al | PROSPERO
|
|
|
6/10/20
|
Tan BWQ, Yeong XL, Tan MLS, et al | PROSPERO
|
|
|
6/10/20
|
Popatia R, Gupta S, Toba N, et al | PROSPERO
|
|
|
6/10/20
|
Herrara Huezo HA, Rodriguez Funes MV, Ortiz Segura DR | PROSPERO
|
|
|
6/10/20
|
Daneshgaran G, Dubin DP, Gould DJ | Research Square
Aim: To collate and categorize the dermatologic findings reported in COVID-19 patients and identify specific lesions that may facilitate diagnosis and prognostication.
|
|
|
6/10/20
|
Maged A, Youssef M | PROSPERO
|
|
|
6/10/20
|
Abbas KS, Khattab EM, Said H, et al | PROSPERO
|
|
|
6/10/20
|
| Cochrane COVID Rapid Reviews
|
|
|
6/10/20
|
| Cochrane COVID Rapid Reviews
|
|
|
6/10/20
|
Gong Y, Yuan K, Liu L | PROSPERO
|
|
|
6/10/20
|
Ferreira de Souza LF, Moura-Fernandes MC, Moreira-Marconi E, et al | PROSPERO
|
|
|
6/10/20
|
Bekteshi V, Gillies C, Seidu S, et al | PROSPERO
|
|
|
6/10/20
|
Cirocchi R, Randolph J, Binda GA, et al | PROSPERO
|
|
|
6/10/20
|
Ibrahim R, Lawal IU | PROSPERO
|
|
|
6/10/20
|
Saktiawati A, Putera D, Triyana K | PROSPERO
|
|
|
6/10/20
|
Mannan SB, Fakruddin, Shishir A, et al | PROSPERO
|
|
|
6/10/20
|
Ali AF, Mohamed M, Tawfik GH, et al | PROSPERO
|
|
|
6/9/20
|
Bwire GM, Nijiro BJ, Mwakawanga DL, et al. | Research Square
Aim: To determine the likelihood of vertical transmission among COVID-19 exposed infants and to determine whether antibodies against Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/ COVID-19 virus exist among COVID-19 vertically exposed but negative infants.
|
|
|
6/9/20
|
Hong DY, Ho E, Vivien WX, et al | PROSPERO
|
|
|
6/9/20
|
Kumar M | PROSPERO
|
|
|
6/9/20
|
Anglemyer A, Parker L, Chiu K, et al | PROSPERO
|
|
|
6/9/20
|
Chanis JC, Levine C, Casiano R, et al | PROSPERO
|
|
|
6/9/20
|
Li H, Chen H, Shi J, et al | PROSPERO
|
|
|
6/9/20
|
Aviani JK, Halim D, Djuwantono T, et al | PROSPERO
|
|
|
6/9/20
|
Fraser S, Sandbach D, Barret S | PROSPERO
|
|
|
6/9/20
|
Serafim TT, Keil P, Okubo R | PROSPERO
|
|
|
6/9/20
|
Rech B, Caixe El Haje LC, de Barros Gallo C, et al | PROSPERO
|
|
|
6/9/20
|
Rike WA, Mequanent S, Makonnen E | PROSPERO
|
|
|
6/9/20
|
Wang W, Ye J, Liang Q, et al | PROSPERO
|
|
|
6/9/20
|
Di Toro F, Gjoka M, De Seta F, et al | PROSPERO
|
|
|
6/9/20
|
Smith E, Ismail Z | PROSPERO
|
|
|
6/9/20
|
Zhen J, Chan C, Thabane L, et al | PROSPERO
|
|
|
6/9/20
|
| CADTH
|
|
|
6/9/20
|
Wei H, Daniels S, Catt H, et al | PROSPERO
|
|
|
6/9/20
|
Deng H, Wang Z, Jiang M, et al | PROSPERO
|
|
|
6/9/20
|
Pourmalek F, Hemami MR, Janani L, et al. | Research Square
Aim: To inform the researchers about the methodology and results of epidemic estimation studies performed for COVID-19 epidemic in Iran, we aimed to perform a rapid review.
|
|
|
6/9/20
|
Singh S, Mittal N, Khera S, et al | PROSPERO
|
|
|
6/9/20
|
Kotecha P, Light A, Checcucci E, et al. | medRxiv
Aim: To evaluate the data currently available regarding the repurposing of different drugs for Covid-19 treatment.
|
|
|
6/9/20
|
Lega JC, Tan BK, Provencher S, et al | PROSPERO
|
|
|
6/9/20
|
Sun Y, Su S, Lu Q, et al | PROSPERO
|
|
|
6/9/20
|
Glenardi G, Mangkuliguna G | PROSPERO
|
|
|
6/9/20
|
Nunes M, Lomardo P, Casado P, et al | PROSPERO
|
|
|
6/8/20
|
Naliga V, Baliga S, Sharma V, et al | PROSPERO
|
|
|
6/8/20
|
Pimenoff VN, Elfstrom M, Dillner J | medRxiv
Aim: To review the evidence on the use of convalescent plasma in patients with COVID-19.
|
|
|
6/8/20
|
Kaung T, Nyi TH, Kyaw I | PROSPERO
|
|
|
6/8/20
|
Li F, Lu H, Li X, et al | PROSPERO
|
|
|
6/8/20
|
Diaz-Arocutipa C, Saucedo-Chinchay JL, Hernandez AV | medRxiv
Aim: To evaluate the association between ACEIs or ARBs use and clinical outcomes in COVID-19 patients.
|
|
|
6/8/20
|
Liu X, Long C, Xiong Q, et al. | medRxiv
Aim: To review the evidence on the use of angiotensin-converting-enzyme(ACE) inhibitors and angiotensin-receptor blockers(ARBs) with the clinical outcomes of coronavirus disease 2019 (COVID-19).
|
|
|
6/8/20
|
Zhu YQ, Duan YN, Tang LL, et al | PROSPERO
|
|
|
6/8/20
|
Chaudhuri S, Bagepally BS, Ponnaiah M, et al | PROSPERO
|
|
|
6/8/20
|
Pegorari MS, Ohara SG, Matos AP | PROSPERO
|
|
|
6/8/20
|
Azmi Y, Yogiwara N, Nugraha RA | PROSPERO
|
|
|
6/8/20
|
Mapanga W, Masukume G, van Zyl DS | PROSPERO
|
|
|
6/8/20
|
Castaneda CA, Castillo M, Rojas JL, et al | PROSPERO
|
|
|
6/8/20
|
Fan X, Jin YR, Lan YQ | PROSPERO
|
|
|
6/8/20
|
Aravena J, Aceituno C, Nyhan K | medRxiv
Aim: To describe the patterns of older adults' mental and psychosocial health related to acute respiratory disease propagated-type epidemics and pandemics and to evaluate the differences with how other age groups respond.
|
|
|
6/8/20
|
Plasencia-Garcia BO, Rodriguez-Menendez G, Rico-Rangel MI, et al. | medRxiv
Aim: To systematically review evidence-based available on drug-drug interactions between COVID-19 treatments and antipsychotics.
|
|
|
6/8/20
|
Wang Y, Li B, Zi H, et al | PROSPERO
|
|
|
6/8/20
|
Pamplona J, Solano R, Soler C, et al. | Research Square
Aim: To conduct a systematic review to describe the epidemiological scientific evidence on gastrointestinal symptoms (GIS), enteric involvement and fecal excretion of SARS-CoV-2 viral RNA and to discuss the possible fecal-oral transmission pathway of COVID-19.
|
|
|
6/8/20
|
Hoste L, Haerynck F | PROSPERO
|
|
|
6/8/20
|
Misra V, Abdel-Qadir H, Lega I, et al | PROSPERO
|
|
|
6/8/20
|
Melos dos Santos AC, Brandao dos Santos B, Correia dos Santos BR, et al | PROSPERO
|
|
|
6/8/20
|
Abate S, Chekole Y, Mantefardo B, et al | PROSPERO
|
|
|
6/8/20
|
Sahay M, Sahoo KC, Dubey S, et al | PROSPERO
|
|
|
6/8/20
|
Riera R, Bagattini A, Pachito D | PROSPERO
|
|
|
6/8/20
|
Iro M, Soundara Pandi SP, Williams A, et al | PROSPERO
|
|
|
6/8/20
|
Karimian M, Jamshidbeigi A, Badfar G, et al | medRxiv
Aim: To evaluate laboratory findings in COVID-19 patients.
|
|
|
6/8/20
|
Alif S, Rabbani G, Robin RC, et al | PROSPERO
|
|
|
6/8/20
|
Shamsuddin A, Nair H, Horne M, et al | PROSPERO
|
|
|
6/8/20
|
Harder T, Markwart R, Haller S, et al | PROSPERO
|
|
|
6/8/20
|
Elshafei M, Oraiby M, Danjuma M, et al | PROSPERO
|
|
|
6/8/20
|
Khadem M, Rasti A, Tanha K, et al | PROSPERO
|
|
|
6/8/20
|
Barros de Oliveira SM, Silva Guimaraes PS, Costa da Silva R, et al | PROSPERO
|
|
|
6/8/20
|
Li BH, Ma LL, Luo LS, et al | PROSPERO
|
|
|
6/8/20
|
Burgos Pineda CS, Aguila Rodrigues BD, Juarez AJ | PROSPERO
|
|
|
6/8/20
|
Chaufan C, Noh KJ, Dutescu I, Fekre H | PROSPERO
|
|
|
6/8/20
|
Ghasemian R, Shamshirian A, Keydari K, et al. | medRxiv
Aim: To review the evidence on the role of vitamin D in COVID-19.
|
|
|
6/8/20
|
Cevik M, Qiu X, Nergiz AI | PROSPERO
|
|
|
6/7/20
|
Gebrie D, Getnet D, Manyazewal T | BMJ Open
|
|
|
6/7/20
|
Mahajan A, Asi KS, Kushal A, et al. | Preprints
Aim: To provide evidence based information in managing dental patients during this pandemic.
|
|
|
6/6/20
|
Hu Z, Yang M, Xie C | Medicine
CANDIDATE THERAPEUTICS
|
|
|
6/6/20
|
Wu L, Dong Y, Li J, et al. | Medicine
|
|
|
6/6/20
|
Wang H, Chen M, Cui W, et al. | Medicine
INFECTION CONTROL
|
|
|
6/5/20
|
Lei XG, Bai L, Sun Z | PROSPERO
|
|
|
6/5/20
|
Rodriguez C, Marin S, Martin A, et al | PROSPERO
|
|
|
6/5/20
|
Kai Z, Tang Q | PROSPERO
|
|
|
6/5/20
|
Taneri PE, Ochoa S, Llanaj E, et al. | medRxiv
Aim: To evaluate biomarkers of anemia and iron metabolism (hemoglobin, ferritin, transferrin, soluble transferrin receptor, hepcidin, haptoglobin, unsaturated iron-binding capacity, erythropoietin, free erythrocyte protoporphyrine, and prevalence of anemia) in patients diagnosed with COVID-19, and explore their prognostic value.
|
|
|
6/5/20
|
Areia A, Mota-Pinto A | PROSPERO
|
|
|
6/5/20
|
Desai A, Gupta R, Li A, et al | PROSPERO
|
|
|
6/5/20
|
Hufstedler H, Barnighasusen T, Matthay E, Rahman S | PROSPERO
|
|
|
6/5/20
|
Mason D, Morris D, Gilbert S, et al | PROSPERO
|
|
|
6/5/20
|
Does obesity independently increase the risk of SARS-COV2 infection and COVID-19 severity and death?
Naude C | Cochrane COVID Rapid Reviews
|
|
|
6/5/20
|
Delgado A, Lira L, Katz L, et al | PROSPERO
|
|
|
6/5/20
|
Fan X, Jin YR, Lan Lan YQ, et al | PROSPERO
|
|
|
6/5/20
|
Shi SZ, Tian J | PROSPERO
|
|
|
6/5/20
|
Shi SZ, Tian J | PROSPERO
|
|
|
6/5/20
|
Gupta A, Paul D, Maurya A | PROSPERO
|
|
|
6/5/20
|
Yao M, Chen W | PROSPERO
|
|
|
6/5/20
|
| Cochrane COVID Rapid Reviews
|
|
|
6/5/20
|
Fontoura IG, Zuil DM | PROSPERO
|
|
|
6/5/20
|
Haile T, Mariye T, Mebrahtom G | PROSPERO
|
|
|
6/5/20
|
Sim KC, Tan JQ, Siew LY | PROSPERO
|
|
|
6/5/20
|
Deng H, Li Z, Zhou Q, et al | PROSPERO
|
|
|
6/5/20
|
Ulloque Badaracco JR, Salas I, et al | PROSPERO
|
|
|
6/5/20
|
Ibrahim E, Ibrahim NE | medRxiv
Aim: To examine all published meta-analyses and systematic reviews on COVID-19 to date to examine available evidence.
|
|
|
6/5/20
|
Li J, Li Y, Li Z, et al | PROSPERO
|
|
|
6/5/20
|
Mangkuliguna G, Glenardi G | PROSPERO
|
|
|
6/5/20
|
| Cochrane COVID Rapid Reviews
|
|
|
6/4/20
|
Liang J, Wang Z, Liang H, et al | PROSPERO
|
|
|
6/4/20
|
Characteristics, quality and volume of the evidence synthesis infodemic - a living systematic review
Abbott R, Whear R, Bethel A, et al | PROSPERO
|
|
|
6/4/20
|
Clinical and tomographic pathognomonic patterns in adult patients with COVID-19: a systematic review
Chavarry Zavaleta EP, Cedano Baca JJ, Minano Terry YX | PROSPERO
|
|
|
6/4/20
|
Brunskill N, Major R, Khunti K, et al | PROSPERO
|
|
|
6/4/20
|
Leach B, Gkousis E, Parkinson S, et al | PROSPERO
|
|
|
6/4/20
|
Ortiz-Munoz L, Rada G | PROSPERO
|
|
|
6/4/20
|
Pati S, Sahoo KC, Dubey S, et al | PROSPERO
|
|
|
6/4/20
|
Kotwal A, Yadav A, Kotwal J | PROSPERO
|
|
|
6/4/20
|
Shi C, Wang L, Ye J, et al. | Research Square
Aim: To assess the potential predictors of mortality in patients with COVID-19.
|
|
|
6/4/20
|
Qiu D, Yan Q, Liu Z, et al | PROSPERO
|
|
|
6/4/20
|
Li J, Li Y, Yue P | PROSPERO
|
|
|
6/4/20
|
Gentile P, Garcovich S | PROSPERO
|
|
|
6/4/20
|
Sun Q | PROSPERO
|
|
|
6/4/20
|
Samaranayake L, Fakhruddin K, Panduwawala C | PROSPERO
|
|
|
6/4/20
|
Loewen S, Pinchoff J | PROSPERO
|
|
|
6/4/20
|
Abdelrazek M, Whittaker T | PROSPERO
|
|
|
6/4/20
|
Keyworth C, Ghio D, Lawes-Wickwar S, et al | PROSPERO
|
|
|
6/3/20
|
Huang S, Wang S, Wang M, et al. | Medicine
CANDIDATE THERAPEUTICS
|
|
|
6/3/20
|
Yang M, Hu Z, Yue R | Medicine
|
|
|
6/3/20
|
Yang Q, Yang X | medRxiv
Aim: To evaluate the association of kidney impairment with the development of COVID-19.
|
|
|
6/3/20
|
Baluku JB, Olum R, Agolor C, et al. | medRxiv
Aim: To determine the prevalence, clinical characteristics and outcomes of HIV and severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) co?infection.
|
|
|
6/3/20
|
Renjun G, Ziyun L, Xiwu Y, et al. | Medicine
|
|
|
6/3/20
|
Sallard E, Lescure F, Burdet C, et al. | medRxiv
Aim: To review the evidence on prophylactic strategies for COVID-19.
|
|
|
6/3/20
|
Chakravorty S, Gloster L, Chahroudi A, et al | PROSPERO
|
|
|
6/3/20
|
Musuuza J, Safdar N, Watson L, et al | PROSPERO
|
|
|
6/3/20
|
LoPresti M, Beck DB, Duggal P, et al. | medRxiv
Aim: To review the literature on host genetic factors related to coronaviruses, with a systematic focus on human studies.
|
|
|
6/3/20
|
Gao K, Song Y, Chen H, et al. | Medicine
|
|
|
6/2/20
|
Haile Y, Fikadu W, Deresse A, et al | PROSPERO
|
|
|
6/2/20
|
Maguire BJ, McLean ARD, Rashan S, et al. | Wellcome Open Research
Aim: To provide an open, accessible and frequently updated resource summarising characteristics of COVID-19 study registrations.
|
|
|
6/2/20
|
Henriques D, Nazario Leao RR, Mota Pinto A, et al | PROSPERO
|
|
|
6/2/20
|
Araujo B, Faria E, Motta L, et al | PROSPERO
|
|
|
6/2/20
|
Wen D, Shi Y | PROSPERO
|
|
|
6/2/20
|
Meremikwu M, Oringanje C, Okebe J, et al | PROSPERO
|
|
|
6/2/20
|
Mitnick C, Franke M, Fung C, et al | PROSPERO
|
|
|
6/2/20
|
Fentahun A, Shifera D | PROSPERO
|
|
|
6/2/20
|
Alanan U, Aljamal M | PROSPERO
|
|
|
6/2/20
|
Padhi BK, Al-Mohaithef, Gupta M, et al | PROSPERO
|
|
|
6/2/20
|
Yao J, Chen L, Zhou S, et al | PROSPERO
|
|
|
6/2/20
|
da Rosa Mesquita R, Freire de Souza CD, Francelino Silva Junior LC, et al | PROSPERO
|
|
|
6/2/20
|
Pandhita BAW, Simadibrata DM | PROSPERO
|
|
|
6/2/20
|
Hei Z, Li H, Guan Y, Wei J | PROSPERO
|
|
|
6/2/20
|
Ssentongo A, Ssentongo P, Heilbrunn E, et al | medRxiv
Aim: To explore the association of RAAS inhibitors, including angiotensin-converting inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortality in patients with hypertension.
|
|
|
6/2/20
|
Sriharan A, Ratnapalan S, Tricco A, et al | CIHR IRSC
Aim: To (a) synthesize the common triggers of stress, burnout, and depression faced by women in health care during the COVID-19 pandemic, and (b) identify individual-, organizational-, and systems-level interventions that can support the well-being of women HCWs during a pandemic.
|
|
|
6/2/20
|
Favoretto C, Lopez de Avila M, Prata Oliveira RA, et al | PROSPERO
|
|
|
6/2/20
|
Abbas KS, Elsaid M, El-Hawary AS, et al | PROSPERO
|
|
|
6/2/20
|
Dinu M, Sofi F, Ambrosio G, et al | PROSPERO
|
|
|
6/2/20
|
Dominski F, Andrade A | PROSPERO
|
|
|
6/1/20
|
Jayant K, Reccia I, Agrawal S | PROSPERO
|
|
|
6/1/20
|
Ma R, Luk A, Yan F, et al | PROSPERO
|
|
|
6/1/20
|
Simadibrata DM, Pandhita BA | PROSPERO
|
|
|
6/1/20
|
Ning J, Yang JH, Tian JH, et al | PROSPERO
|
|
|
6/1/20
|
Wang Y, Liang S, Qiu T, et al. | medRxiv
Aim: To critically assess the published studies of Chloroquine (CQ) and hydroxychloroquine (HCQ) for the treatment of COVID-19 and provide recommendations for future clinical trials for the COVID-19 pandemic.
|
|
|
6/1/20
|
Juan CA, Libunao J | PROSPERO
|
|
|
6/1/20
|
Moyo D, Iroh Tam PY | PROSPERO
|
|
|
6/1/20
|
Duarte G, Ortiz-Munoz L, Morales MB, et al | PROSPERO
|
|
|
6/1/20
|
Rosa de Sousa Neto A, Batista de Carvalho AR, | PROSPERO
|
|
|
6/1/20
|
Liu L, Lun Z, Li H, et al | PROSPERO
|
|
|
6/1/20
|
Xiong X, Wang Z, Xia Z, et al | PROSPERO
|
|
|
6/1/20
|
Jafari A, YektaKooshali | PROSPERO
|
|
|
6/1/20
|
Zhao J, Yang L | PROSPERO
|
|
|
6/1/20
|
The prevalence of comorbidities and cardiovascular complications in critically ill COVID-19 patients
Aguiar A, Farinasso C, Andrade K, et al | PROSPERO
|
|
|
6/1/20
|
Aguiar A, Farinasso C, Andrade K, et al | PROSPERO
|
|
|
5/31/20
|
Billah A, Miah M, Khan N | medRxiv
Aim: To provide the average reproductive number of COVID-19 based on available global level evidence.
|
|
|
5/30/20
|
Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, et al. | Preprints
Aim: To review the evidence on the epidemiologic relationship between smoking and COVID-19. UPDATED
|
|
|
5/29/20
|
Mohan M, Navti O, Okunoye G, et al | PROSPERO
|
|
|
5/29/20
|
Standing J, Gastine S, Pang J, et al | PROSPERO
|
|
|
5/29/20
|
Venkatesulu BP, Chandrasekar VT, Giridhar P, et al. | medRxiv
Aim: To assess clinical outcomes in cancer patients affected by COVID-19.
|
|
|
5/29/20
|
Wang X, Xie P, Sun G, et al | PROSPERO
|
|
|
5/29/20
|
Liou JM, Chen MJ | PROSPERO
|
|
|
5/29/20
|
Liu C, Shi Y, He Y | Research Square
Aim: To review the evidence on the characteristics of children with COVID-19. UPDATED
|
|
|
5/29/20
|
Zhao X, Lei Z, Gao F | PROSPERO
|
|
|
5/29/20
|
Silva EP, Melo PA, Costa SR | PROSPERO
|
|
|
5/29/20
|
Wang Z, Deng H, Ou C, et al. | Research Square
Aim: To assess clinical characteristics, comorbidities, and complications in severe and non-severe patients with COVID-19.
|
|
|
5/29/20
|
Steffen R, Zugliani M | PROSPERO
|
|
|
5/29/20
|
Shamshirian A, Hessami A, Heydari K, et al. | medRxiv
Aim: To examine the effectiveness of hydroxychloroquine in treatment of COVID-19. UPDATED
|
|
|
5/29/20
|
Ssentongo P, Ssentongo A, Heilbrunn E, et al | PROSPERO
|
|
|
5/29/20
|
Karunanithi S, Shreedevi MS, Nandhagopal K, et al | PROSPERO
|
|
|
5/29/20
|
Azam M, Ratnawati M, Fibriana AI, et al | PROSPERO
|
|
|
5/29/20
|
Chen T, Zhao MX, Yang KL, et al | PROSPERO
|
|
|
5/29/20
|
Smith E | PROSPERO
|
|
|
5/29/20
|
Marzaleh MA, Khoundabi B | PROSPERO
|
|
|
5/29/20
|
Zaikin I, Matok I, Rotshild V, et al | PROSPERO
|
|
|
5/29/20
|
Lu P, Fan Y, Liu Y, et al | PROSPERO
|
|
|
5/29/20
|
Dalui SK, Chatterjee S, Pattanaik S | PROSPERO
|
|
|
5/29/20
|
Allana A, Aziz S, Saleem F | Research Square
|
|
|
5/29/20
|
Wu T, Zou Z | PROSPERO
|
|
|
5/28/20
|
Stewart I, Khan F, Fabbri L, et al. | PROSPERO
|
|
|
5/28/20
|
Braithwaite I, Callender T, Bullock M, et al. | medRxiv
Aim: To assess the effectiveness of automated and semi-automated digital tools for contact tracing, and identify key considerations for successful implementation, to inform the control of COVID-19. UPDATED
|
|
|
5/28/20
|
Palaiodimos L, Chamorro-Pareja N, Karamanis D, et al. | medRxiv
Aim: To systematically review and synthesize with a meta-analysis the available observational studies reporting the effect of diabetes in mortality among hospitalized patients with COVID-19.
|
|
|
5/28/20
|
Wu K | PROSPERO
|
|
|
5/28/20
|
Huang G, Li W | PROSPERO
|
|
|
5/28/20
|
Brunner TM, Fatrin S, Susilo A, et al | PROSPERO
|
|
|
5/28/20
|
Jiang C, Hou B | PROSPERO
|
|
|
5/28/20
|
Fisher J, Chang YS, Chien LY, et al | PROSPERO
|
|
|
5/28/20
|
Berhe DF, Cherinet T, Michael K | PROSPERO
|
|
|
5/28/20
|
Lee J, Yang IJ | PROSPERO
|
|
|
5/28/20
|
Ocskay K, Juhasz MF, Hegyi P, et al | PROSPERO
|
|
|
5/28/20
|
Ali MW, Farooq S | PROSPERO
|
|
|
5/28/20
|
Ali N, Khoja A, Kazim F | PROSPERO
|
|
|
5/28/20
|
Ssentongo P, Ssentongo A, Heilbrunn E, et al | PROSPERO
|
|
|
5/28/20
|
Xiao L, Fu L, Hong K, et al. | PROSPERO
|
|
|
5/28/20
|
Ssentongo P, Ssentongo A, Heilbrunn E, et al | PROSPERO
|
|
|
5/28/20
|
Roshandel R, Badr TA, Motlagh RS, et al | PROSPERO
|
|
|
5/27/20
|
Takhelchangbam ND, Saxena D, Jain PK, et al | PROSPERO
|
|
|
5/27/20
|
Arab-Zozani M, Miri MR, Moshtagh M, et al | PROSPERO
|
|
|
5/27/20
|
Singh A, Hussain S, Mirchandani DA, et al. | Research Square
|
|
|
5/27/20
|
Tunjungputri RN, Tetrasiwi EN, Lubis AM, et al | PROSPERO
|
|
|
5/27/20
|
Abdelmoaty M | PROSPERO
|
|
|
5/27/20
|
Juan CA, Libunao | PROSPERO
|
|
|
5/27/20
|
Piscoya A, Ng-Sueng LF, del Riego AP, et al. | medRxiv
Aim: To evaluate the efficacy and safety of remesdivir for the treatment of COVID-19.
|
|
|
5/27/20
|
Dias de Oliveira JM, Oliveira LB, Pauletto P, et al | PROSPERO
|
|
|
5/27/20
|
Tamara A, Kok LT, Raharja A | PROSPERO
|
|
|
5/27/20
|
Diaz-Arocutipa C, Saucedo-Chinchay J | PROSPERO
|
|
|
5/27/20
|
Dubey S, Sahoo KC, Sahay MR | PROSPERO
|
|
|
5/27/20
|
Tan BK | PROSPERO
|
|
|
5/27/20
|
Diaz-Arocutipa C, Saucedo-Chinchay J, Torres-Velencia J, et al | PROSPERO
|
|
|
5/27/20
|
Xue Y, Sun S | PROSPERO
|
|
|
5/27/20
|
Hitch D, Cramer E, Adcock E, et al. | Research Square
Aim: To inform health services planning and decision making, by identifying and synthesizing the potential functional impact of the Covid-19 pandemic on human health and wellbeing.
|
|
|
5/27/20
|
Ptino MA, O'Conner DL, McGeer AJ, et al. | medRxiv
Aim: To characterize the effect of commonly used pasteurization techniques on viruses in HM and non-HM matrices.
|
|
|
5/27/20
|
Xiao L, Fu L, Hong K | PROSPERO
|
|
|
5/27/20
|
Ortiz-Munoz L, Duarte G, Belen Morales M, et al. | PROSPERO
|
|
|
5/26/20
|
Ran L, Wang M | PROSPERO
|
|
|
5/26/20
|
Graber K, Byrne E, Goodacre E, et al. | PsyArXiv
Aim: To review of the impact of quarantine, isolation, or other restrictive environments on children’s play and whether play may mitigate the adverse effects of such restrictions.
|
|
|
5/26/20
|
Souza KM, Figueiro M, Yonekura T, et al | PROSPERO
|
|
|
5/26/20
|
Chakraborty S, Sagar S, Kirubakaran R, et al | PROSPERO
|
|
|
5/26/20
|
Garg A, Rout A, Sharma A, et al. | medRxiv
Aim: To study the cumulative evidence for association of ACEI/ARB use with outcomes among patients with confirmed Covid-19.
|
|
|
5/26/20
|
Shaw J | Women's College Hospital
|
|
|
5/26/20
|
Wang Y, Hu XY, Wardle J, et al | PROSPERO
|
|
|
5/26/20
|
Subramanian MS, Gunasekaran V, Thakral M, et al | PROSPERO
|
|
|
5/26/20
|
Fireman K, Leite E, da Silva Barbosa MA, et al | PROSPERO
|
|
|
5/26/20
|
Zaki MM, Elgharably AA, Al-Jawlahi RH, et al. | PROSPERO
|
|
|
5/26/20
|
Dambha-Miller H, Albasri A, Hodgson S, et al. | medRxiv
Aim: To review evidence on routinely prescribed drugs in the UK that could up or downregulate Angiotensin Converting Enzyme 2 (ACE2) and potentially affect COVID-19 disease.
|
|
|
5/26/20
|
Li K, Wu X, Zhong Y, et al. | medRxiv
Aim: To evaluate the diagnostic value of chest CT in 2019 novel coronavirus disease (COVID-19), using the reverse transcription polymerase chain reaction?RT-PCR?as a reference standard.
|
|
|
5/26/20
|
Misra S, Nath M, Hadda V, et al. | medRxiv
Aim: To conduct a systematic review and meta-analysis to assess the effect of various treatment modalities in nCOV-2019 patients.
|
|
|
5/26/20
|
Singh S, Moore TJ | medRxiv
Aim: To systematically evaluate their efficacy and safety in hospitalized patients with COVID-19.
|
|
|
5/26/20
|
Getaneh Y, Yizengaw A, Adane S, et al. | medRxiv
Aim: To review the evidence on alternative public health strategies to control the spread of coronavirus disease 2019.
|
|
|
5/26/20
|
De Rubeis V, Anderson L, Lee J, et al | PROSPERO
|
|
|
5/26/20
|
Okechukwu A, Marrero DG, Palmer K | PROSPERO
|
|
|
5/26/20
|
Alexander PE, Piticaru J, Lewis K, et al. | medRxiv
Aim: To explore whether the use of remdesivir, initially an experimental broad-spectrum antiviral, is effective in the treatment of hospitalized patients with COVID-19.
|
|
|
5/26/20
|
Chen J, Zhai C, Wang Z, et al | PROSPERO
|
|
|
5/26/20
|
Nugroho D, Icanervilia AV, Patria YN, et al | PROSPERO
|
|
|
5/26/20
|
Katsanos A, Palaiodimou L, Zand R, et al | PROSPERO
|
|
|
5/26/20
|
Ng JJ, Liang ZC, Choong A | PROSPERO
|
|
|
5/26/20
|
Wang W, Qin L, Su H, et al | PROSPERO
|
|
|
5/26/20
|
The role of physiotherapy in the long-term physical and mental health of people recovered from COVID
Dhiman N, Gyanpuri V | PROSPERO
|
|
|
5/26/20
|
Ocagli H, Pergola V, Mancuso D, et al | PROSPERO
|
|
|
5/25/20
|
Bezabih YM, Bezabih A, Alamneh E, et al. | medRxiv
Aim: To review the effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19).
|
|
|
5/25/20
|
Burton C, Coles B, Anisesh A, et al. | medRxiv
Aim: To identify the range of filtering respirators that can be used in patient care and synthesise evidence to guide the selection and use of different respirator types.
|
|
|
5/24/20
|
Viner RM, Mytton OT, Bonell C, et al. | medRxiv
Aim: To review the evidence on the susceptibility to and transmission of SARS-CoV-2 by children and adolescents compared with adults.
|
|
|
5/24/20
|
Buitrago-Garcia, DC, Egli-Gany D, Counotte MJ, et al. | medRxiv
Aim: To explore the evidence on asymptomatic people with SARS-CoV-2.
|
|
|
5/23/20
|
Beale S, Hayward A, Shallcross L, et al. | medRxiv
Aim: To review current evidence regarding the asymptomatic proportion of PCR-confirmed SARS-CoV-2 infections based on methodologically-appropriate studies in community settings.
|
|
|
5/23/20
|
Zahedi M, Yousefi M, Abounoori M, et al. | medRxiv
Aim: To assess the effect of Novel Coronavirus Disease on liver function.
|
|
|
5/23/20
|
Geisler BP, Zahabi L, Lang AE, et al. | medRxiv
|
|
|
5/23/20
|
Weiss A, Jellingsoe M, Sommer M | medRxiv
Aim: To provide a coherent overview from published studies of the duration of viral detection and viral load in COVID-19 patients, stratified by specimen type, clinical severity and age.
|
|
|
5/23/20
|
Ssentongo P, Ssentongo AE, Heilbrunn ES, et al. | medRxiv
Aim: To explore the association of pre-existing conditions with COVID-19 mortality.
|
|
|
5/23/20
|
Koh WC, Naing L, Rosledzana MA, et al. | medRxiv
Aim: To review the evidence on SARS-CoV-2 transmission dynamics.
|
|
|
5/22/20
|
A Rapid Review of the Pathoetiology, Presentation and Management of Delirium in Adults with COVID-19
Hawkins M, Sheehan KA, Bonato S, et al | PROSPERO
|
|
|
5/22/20
|
Taheri L, Naiery MD, Gheiasi F, et al | PROSPERO
|
|
|
5/22/20
|
Amancio A, Farias K, Pitta G | PROSPERO
|
|
|
5/22/20
|
Wong CKH, Wong JY, Tang EHM, et al. | Research Square
Aim: To conduct a systematic review and meta-analysis on the comorbidities, symptoms, clinical characteristics and treatment of COVID-19 patients.
|
|
|
5/22/20
|
Kim MS, Kim WJ, An MH | medRxiv
|
|
|
5/22/20
|
Chen C, Li Y | PROSPERO
|
|
|
5/22/20
|
James P, Ali Z, Armitage A, et al | PROSPERO
|
|
|
5/22/20
|
Chen C, Li Y | PROSPERO
|
|
|
5/22/20
|
Robbins T, Arvantis T, Randeva H, et al | PROSPERO
|
|
|
5/22/20
|
Mittal N, Singh S, Mittal R, et al | PROSPERO
|
|
|
5/22/20
|
Schneider J, Gibson B, Talamonti D, et al | PROSPERO
|
|
|
5/22/20
|
Luo Y, Li Y, Dai J | medRxiv
Aim: To review the evidence on the effect of body sodium on SARS-CoV-2 infection.
|
|
|
5/22/20
|
Hajikhani B, Nasiri MJ, Jamshidi P | PROSPERO
|
|
|
5/22/20
|
Power R, Lowery M | PROSPERO
|
|
|
5/22/20
|
Barbis W, Hayley A, Shehabi | PROSPERO
|
|
|
5/22/20
|
Zuercher SJ, Kerksieck P, Adamus C, et al. | medRxiv
Aim: To review the evidence on MHP prevalence rates published since 2000, during and after epidemics, including the general public, health care workers, and survivors.
|
|
|
5/22/20
|
Puyat J, Ahmad H, KazanJiang A, et al | PROSPERO
|
|
|
5/22/20
|
Chigwedere OC, Arensman E, Kabir Z, et al | PROSPERO
|
|
|
5/22/20
|
Liu M, Gao Y, Shi S, et al | PROSPERO
|
|
|
5/22/20
|
Ma L, Song YP, Gao K, et al | PROSPERO
|
|
|
5/22/20
|
Labad J, Gonzalez-Rodriguez A, et al | PROSPERO
|
|
|
5/22/20
|
Liang F, Tian L | PROSPERO
|
|
|
5/21/20
|
Zhang K, Zhang G, Cui W, et al. | PROSPERO
|
|
|
5/21/20
|
Delanerolle G, Raymont V, Griffiths J, et al. | PROSPERO
|
|
|
5/21/20
|
Greene E, O'Connell R, Murphy M, et al. | PROSPERO
|
|
|
5/21/20
|
Alabool H, Alarabiat D, Abualigah L, et at. | Research Square
Aim: To present a comprehensive systematic review on the application of AI techniques in containment the COVID-19 pandemic.
|
|
|
5/21/20
|
Maheshkumar K, Venugopal V | PROSPERO
|
|
|
5/21/20
|
Madigan S, Racine N, McArthur BA, et al. | PROSPERO
|
|
|
5/21/20
|
Xu M, Yao D, Han L, et al | PROSPERO
|
|
|
5/21/20
|
Arensman E, Brenna C, Cha Y, et al | PROSPERO
|
|
|
5/21/20
|
Li Y, Kuper H | PROSPERO
|
|
|
5/20/20
|
Sinha A, Nayak S, Dehuri P, et al. | PROSPERO
|
|
|
5/20/20
|
Nugroho D, Pramono B, Senorita H, et al. | PROSPERO
|
|
|
5/20/20
|
Shukla M, Shukla KG | PROSPERO
|
|
|
5/20/20
|
Tleyjeh IM, Bin Abdulhak AA, Tlayjeh H, et al. | Research Square
Aim: To systematically review the literature and perform a meta-analysis about prior use of ACEI/ARBs and risk of SARS-CoV-2 infection.
|
|
|
5/20/20
|
Xia L, Liu Z, Liu Z, et al. | PROSPERO
|
|
|
5/20/20
|
Lin K, Guo Y, Yan H, et al. | PROSPERO
|
|
|
5/20/20
|
Sales-Peres S, Sales-Peres M, Azevedo-Silva LJ, et al. | PROSPERO
|
|
|
5/20/20
|
Dorrell R, Barash E, Lichtig A, et al. | PROSPERO
|
|
|
5/20/20
|
Fan Y, Fan Y, Liu W, et al. | PROSPERO
|
|
|
5/20/20
|
Iezadi S, Gholipour K, Ghiasi A, et al. | PROSPERO
|
|
|
5/20/20
|
Leone S, da Costa Marques AP, Reis FP, et al. | PROSPERO
|
|
|
5/20/20
|
Savioli F, dos Santos L, Duarte ML, et al. | PROSPERO
|
|
|
5/20/20
|
Arvanitis T, Ramaiya E, Bhalodiya J, et al. | PROSPERO
|
|
|
5/20/20
|
Hosseini MS, Akbarzadeh MA, Vaez Y | PRO |